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 Abstract 
 
Structure-based drug design (SBDD) is defined as the use of three-dimensional structural 
data to advance lead development and optimization studies. Many SBDD projects have used a 
rigid protein structure to represent the receptor target in order to gain greater throughput with 
minimal computational time. However, numerous studies have illustrated the significant influence 
protein flexibility exerts upon binding predictions. Inclusion of protein flexibility has become 
essential due to the need for ligands with novel scaffolds and unique modes of action that combat 
increasing rates of drug resistance and decreasing approval of clinical candidates. Additionally, 
accurate modeling of protein flexibility may reveal unknown allosteric sites and increase the 
number of viable lead compounds for a given target.  
Previously, Carlson et al. incorporated structural flexibility into pharmacophore modeling 
through the development of the multiple protein structure (MPS) method (2000). This technique 
was the first computational-mapping algorithm to identify experimentally-validated lead 
compounds. Probe mapping is a common computational technique for identifying potential 
binding pockets along a protein surface. However, the efficacy of most methods has been limited 
by neglecting desolvation penalties. To broaden the impact of our studies, we have developed an 
improved technique for probe mapping, Mixed Solvent Molecular Dynamics (MixMD), which 
extends our MPS approach by simultaneously incorporating flexibility and solvent competition. 
This technique has been validated on the canonical hen egg-white lysozyme system and has been 
generalized across a series of pharmaceutically-relevant targets. MixMD can be used to develop 
accurate pharmacophores of druggable hot spots through the incorporation of several different 
probe types. 
As a complement to our methodology development, we have specifically targeted protein 
flexibility in another canonical protein system. HIV-1 Protease (HIVp) is an exceptional test case 
due to the abundance of structural data available, its importance as a pharmaceutical target, and 
 xxv 
 
its potential for allosteric regulation. Three allosteric sites have been hypothesized for HIVp: the 
elbow site, the eye site, and the dimer interface. We have used MD simulations to probe the 
allosteric control possible at the elbow and eye sites by small molecules. Our studies have 
identified important features for designing effective allosteric inhibitors of HIVp. 
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Chapter 1  
Introduction 
1.1  Specific Aims 
The specific aims of my study encompassed 1) the development of an improved method 
for mapping flexible targets, based upon our achievements with the Multiple Protein 
Structure (MPS) method and 2) the investigation of potential allosteric regulation of 
HIV-1 Protease (HIVp). 
My underlying hypothesis was that better techniques for structure-based drug design 
(SBDD) enable the discovery of ligands with new scaffolds and novel modes of action. 
We expected that through the incorporation of protein flexibility and new surface-
mapping methods, an improvement would be seen in terms of site-prediction accuracy as 
well as identification of potential allosteric sites.  
My long-term goal has been to advance the current state of SBDD through studies that 
improve our understanding of the impact of protein flexibility on binding. Through 
successful mapping studies of pharmaceutically-relevant targets using the MPS method, 
the Carlson group has demonstrated that receptor flexibility enables results to surpass the 
known limitations of rigid models; my research has built from that success. 
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1.2 Theory of Molecular Mechanics 
Computer technology has rapidly progressed, enabling the simultaneous advance of 
computational tools for basic and applied science. Medicinal chemistry has particularly 
benefitted from technological advances that allowed detailed analyses of binding 
characteristics in pharmaceutically-relevant target systems. Several computational 
methods have been developed for studying macromolecular systems, ranging from 
quantum mechanics (QM) to molecular mechanics (MM). Although QM provides 
information on energetic interactions at the atomic scale at the highest possible level of 
accuracy, their huge computational cost has rendered them infeasible for large systems 
(greater than 100 atoms). MM is based on statistical mechanics theory; therefore, it can 
be used to predict the energy of biomolecular systems with reasonable accuracy. In MM, 
the potential energy for all atoms in the system is calculated from the sum of the covalent 
(bond, angle, dihedral) and noncovalent (van der Waals, dipole, coloumbic) 
contributions, according to a user-specified force field.  
Force fields contain the applied energy function and the set of parameters used to 
describe all atoms within the system. These parameters are usually derived from high 
quality experimental and QM data that represent a typical biomolecular system (proteins, 
nucleic acids, lipids, small organic molecules). Numerous parameter sets exist for each 
MM program, but combining or transferring parameter sets across force fields and/or 
programs is inadvisable.   
The stochastic Monte Carlo (MC) method and the deterministic molecular dynamics 
(MD) method are two forms of MM simulation.1 MC is reliant on a distribution of 
probabilities to randomly sample the potential energy surface of a system, while MD 
integrates over Newton’s equations of motion to dynamically sample the energy 
landscape: 
€ 
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dt 2 . Here, Fi is the force exerted on atom i, mi 
the atomic mass of i, ai the acceleration of i, and V the potential energy of the system. 
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These terms define the bond-stretching, angle-bending, torsion-rotation, van der Waals 
(vdW), and electrostatic forces respectively. Bond stretching and angle bending are 
described by a harmonic oscillator function, torsions by a periodic function, vdW 
interactions by the Lennard-Jones potential, and electrostatics by Coulomb’s Law.1 
Usually, the positions of the atoms are given by a crystal or NMR structure placed within 
a computer-generated solvent box. Velocities are assigned to the starting xyz coordinates 
based on a Maxwell-Boltzmann distribution, where the magnitude is proportional to the 
user-defined temperature. The potential energy is calculated based on the atomic 
coordinates, and the individual atoms accelerate/decelerate according to the resultant 
force. Time is advanced by a user-specified timestep (usually 2 fs), and each step 
calculates new atomic positions, velocities, and forces according to the Verlet integrator3. 
The appropriate timestep is dependent on the fastest motions within the system; therefore, 
bonds to hydrogen are typically restrained4 to allow a larger timestep.  
Since MC simulations involve random-step searches of the energy landscape, they 
cannot provide a time-dependent view of the system at a given temperature. However, 
MD is capable of describing of the system’s energetics over a simulation time. True 
system dynamics are not observed in most MD because coupling to a temperature bath 
scales velocities at various intervals. Assuming the veracity of the ergodic hypothesis, 
which states that all available microstates of the system will be sampled given an 
“adequate” timescale,5 both MC and MD should give appropriate distributions of states if 
run long enough. To optimize sampling, it is frequently desirable to perform multiple 
shorter simulations instead of one long simulation.   
In the Carlson Lab, MD is applied to biomolecular systems through the program 
AMBER (Assisted Model Building with Energy Refinement).6 Under a nonpolarizable 
force field, individual atoms are represented as spheres with assigned vdW radii and a 
constant net charge. The basic force field used within AMBER is described by the 
potential energy function. Several force fields are available for use with MD simulations, 
and the choice of which to implement is dependent on efficacy, performance, and the 
system under study. When the original FF94 parameter set was shown to overstabilize α-
helices, continual evolution of the force field over time led to the development of 
FF99SB.7 Studies comparing computational results with experimental data strongly 
 4 
 
support the accuracy of this parameter set for most proteins in AMBER, thus we have 
chosen to apply FF99SB in our protein-ligand systems. 
In simulations of a biomolecular complex in solution, the explicit inclusion of water 
molecules can greatly impact simulation time. In some cases, exploration of the motion 
of the biomolecule is more important than observing specific solute-solvent interactions; 
the solvent can be represented implicitly by a continuum model. A number of continuum 
solvent models have been developed, the most prevalent being the generalized Born (GB) 
model.8 Our calculations involving the generalized Born approach involved the use of a 
modified set of parameters published by Onufriev et al, GBOBC.9  
The generalized Born/surface area model mimics the effect of solvent through the 
addition of two terms to the “vacuum” potential energy function previously noted as the 
basic force field for molecular mechanics: ΔGsol = (1−
1
εij
∑ )(qiqj / fGB (rij ))+ A σ i
i
∑ .10 
These terms define the polar component of the solvation free energy and the non-polar 
contribution, which is proportional to the surface area of molecule A. The term fgb is a 
smoothing function, which depends upon the atomic radii and interatomic distances rij. 
The advantage to implicit solvation is that it allows calculations to be performed at a 
reduced expense because solvent motion does not need to be explicitly calculated. 
Additionally, the lack of viscous drag from the solvent allows the molecule of interest to 
move more quickly through the potential energy space available. In order to more 
accurately account for explicit solvent-solute interactions, Langevin dynamics (LD) were 
employed to account for the random buffeting of the solute by the solvent. The Langevin 
equation is based on Newtonian physics and models continuum solvent interactions 
through the relationship; 
mi
d 2ri
dt2 = Fi{ri (t)}−ξ
dri (t)
dt + Ri (t)  
where R is defined as the random force and ξ as the frictional coefficient.1 
1.3 Structure-based Drug Design 
Structure-based drug design (SBDD) involves the use of three-dimensional structural 
data to advance lead identification and subsequent optimization for drug discovery. The 
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exponential growth of the PDB and improvement in homology modeling techniques 
makes SBDD applicable to an ever-growing number of pharmaceutically-relevant targets 
with a three-dimensional structure available. SBDD studies are generally centered upon 
at least one of the following three goals: prediction of binding modes, prediction of 
binding affinities, and prediction of novel binding partners. Depending on these goals and 
available data, SBDD can involve different approaches, which are often separated into 
docking techniques and de novo design. Docking is implemented to predict the binding 
mode and affinity of small molecules. When docking is applied to a large compound 
database, it is referred to as virtual screening (VS) and often centered on the prediction of 
new ligands with high affinity for a target molecule to enrich the compound set for 
experimental testing. De novo design is performed with the intent of predicting new 
compounds in novel chemical space. Fragment-mapping techniques that use functional 
groups to probe binding sites are often applied for this type of approach. Over the past 20 
years, these SBDD studies have produced viable leads, enabling the development of 
successful clinical drugs and leading to the extensive implementation of SBDD in 
medicinal chemistry research.11-13 
X-ray crystallography and NMR studies have clearly demonstrated conformational 
differences between many receptors’ holo (bound) and apo (unbound) states. Sampling 
ligand conformations is straightforward; most SBDD protocols now include ligand 
flexibility (with on-the-fly sampling being superior to a rigid set of pre-generated 
conformations), yet this is insufficient for the most accurate results. Despite data 
demonstrating the influence of protein flexibility on ligand binding, most SBDD efforts 
still rely upon a static receptor structure because of the resources required to account for 
its many degrees of freedom. Although a few proteins can have their binding potential 
represented with a single, fixed conformation, for most systems the information presented 
by a rigid structure is simply inadequate.  
In a comparative study of 10 docking programs and 37 scoring functions, no single 
method outperformed the others when performing rigid docking of diverse compounds to 
a set of eight proteins.14 The scoring functions were unable to accurately predict binding 
affinity or relatively rank the compounds. Ginalski and co-authors evaluated the binding 
predictions and scoring results for 1,300 protein-ligand complexes from PDBbind 2007 
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with Surflex, LigandFit, Glid, GOLD, FlexX, eHiTS, and AutoDock.15 The authors found 
that the programs achieved a mean RMSDTop-Sscore that ranged from 2.77 Å (GOLD) to 
4.37 Å (FlexX) for the docked poses, none of the scoring functions were able to achieve a 
reasonable correlation between the pose score and the experimental activity. Several 
recent reviews have been published that discuss the deficiencies of existing scoring 
functions for docking.14,16-20 Klebe and coworkers hypothesized that there is an intimate 
link between docking and scoring, postulating that correct prediction of accurate binding 
geometries will simultaneously solve the scoring problem.21-23 Therefore, while we 
acknowledge the limitations of current scoring functions, we focus on the variety of 
techniques for incorporating protein flexibility in SBDD.  
A number of reviews have included some consideration of the impact of protein 
flexibility on drug discovery.16,21,24-34 Many of these reviews concentrated on only a subset 
of protein flexibility methods or emphasized a particular technique. Here, we examine a 
variety of techniques that account for flexibility in protein-ligand binding, not only 
studies where the primary focus is on docking but also studies that concentrate on 
binding-site mapping.  
 
1.4 Protein Flexibility 
1.4.1. Conformational variability 
Our understanding of receptor-ligand binding has significantly advanced from the 
original lock-and-key model proposed by Fischer.35 Early experimental studies showed 
that the act of ligand binding influences the protein conformation, referred to as 
conformational induction or induced fit.36 Another model of ligand binding is 
conformational selection, wherein the ligand chooses a binding partner from among 
available states in the conformational ensemble, thereby shifting the population 
distribution.37-42 Recently, several papers have been published examining the evidence for 
whether receptor binding occurs because of induced fit or conformational selection. 
Sullivan and Holyoak studied the kinetics of phosphoenolpyruvate carboxykinase and 
concluded that induced fit and conformational selection were not mutually exclusive, 
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rather they were complementary avenues for binding.43 Weikl and von Deuster developed 
equations of binding kinetics using a four-state protein-ligand complex to distinguish 
between induced and selected fit.44 Hammes et al. examined the binding pathways for 
dihydrofolate reductase (DHFR) and flavodoxin and determined that a mixed binding 
mechanism was most likely.45 They noted that the relative importance of induced fit or 
conformational selection for a particular case could be analyzed by comparing the 
reaction path flux. Both mechanisms of binding will produce the same result; it is 
important only that some mechanism of receptor conformational change be incorporated 
in docking simulations. This is particularly useful in SBDD because it implies that 
computationally inexpensive methods that include protein flexibility should correctly 
predict binding modes. 
1.4.2. Allostery 
Protein-ligand flexibility upon binding is crucial for proper understanding of 
allosteric regulation. Nussinov and coauthors postulated that most proteins exist in an 
ensemble of states, and thus most proteins have the potential for allostery.46 Based on 
experimental literature, they demonstrated that the binding of an allosteric ligand shifted 
the population of conformational substates, thereby influencing the ability of other 
ligands to bind an alternate site.  
Drug resistance is a growing problem that calls for new approaches to drug therapy. 
By exploring allosteric control in protein targets, we can find new modes of action and 
hence, overcome emergent resistance, and develop cocktails of drugs to improve 
treatment.  
 
1.5 Protein-Ligand Binding 
1.5.1. The Cross Docking Problem 
Research into protein flexibility and allostery has lent support to the importance of 
representing multiple states in binding studies (Figure 1-1). Mobley and Dill noted that 
binding free energy (ΔGbind) and entropy are influenced by the shape and width of the 
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entire conformational landscape, rather than a single rigid pose.47 Murray et al. examined 
approaches for using rigid receptors in docking studies.48 When the authors attempted to 
dock a known ligand into a protein structure solved in the presence of a different ligand 
(referred to as cross-docking), they found that the active site was biased towards to the 
native ligand (Figure 1-2). A variety of differences in the surface of the binding site were 
identified for the same protein solved with different ligands or in the absence of a ligand. 
Movement was observed in the backbone, side chain (both dependent and independent of 
the backbone Cα), and active site metals. As a consequence, active sites were biased 
towards a particular ligand type, negatively impacting docking efforts. The resultant 
misdocking could not be overcome without accounting for critical conformational shifts. 
Najmanovich et al. examined the percentage of residues that actually undergo a change 
upon ligand binding, based on two non-redundant datasets containing paired holo and apo 
protein structures from the PDB.49 No significant correlation was found between 
backbone movement and side chain flexibility, but Lys, Arg, Gln, and Met were 
identified as the residues most likely to demonstrate side-chain rearrangement upon 
ligand binding. Najmanovich et al. showed that 60-70% of the binding site undergoes 
some change in side chain orientation. Taken together, these studies clearly illustrated 
that the lack of protein flexibility in typical SBDD efforts severely limits the 
identification of true ligands and accurate docked poses.  
 
Figure 1-1: The conformational variation in holo and apo BACE structures illustrates structural 
differences frequently seen across multiple crystal structures of the same protein. 
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Figure 1-2: The same protein crystallized with different ligands. This simple two ligand-one protein set 
demonstrates the influence of structure on the shape of the binding pocket. 
An underlying assumption in rigid docking efforts is that the complexed state is the 
lowest free energy state. However, the ligand-bound state is not always the lowest energy 
state for either the protein or the ligand. Smith et al. were first to examine conformational 
similarity, they compared the four available structures of interleukin-4, two from NMR 
and two from crystallography.50 They found that differences in the experimental methods 
clearly affected the structure, and that the two NMR structures were more similar to the 
crystal structures than to each other. Further, they noted that the exposed regions of the 
surface, particularly the highly flexible loops, showed the largest conformational 
difference among the structures. Eyal et al. evaluated a set of 659 structure pairs from the 
PDB and showed that experimental variation in protein structures certainly exists, as a 
result of refinement, crystal packing, and/or crystallization conditions.51 Chopra et al. 
employed MD on a set of 75 proteins to explore the role of solvent in structural 
determination and concluded that solvent effects have an enormous influence on the final 
refined protein structure.52 
1.5.2. Sources of Structural Information 
Use of a set of similar conformations only generates a finite amount of information on 
potential binding partners. Additional receptor space should be explored, especially in 
scenarios where alternate binding modes are of interest. X-ray crystallography, NMR 
structures, homology models, normal mode analysis (NMA), and molecular mechanics 
simulations are all potential sources of structural diversity. Advances in technology have 
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allowed for significant increases in available structural information for a vast number of 
receptor targets. The Protein Data Bank (PDB) now contains over 74,601 structures (as of 
7/19/11), up from 13,605 structures in 2000.53 Several research groups, as well as 
thousands of computer users, have dedicated their computer power to distributed 
structure prediction of proteins with Folding@HOME, POEM@HOME, and 
Rosetta@HOME. Martin-Renom et al. estimated that almost one-third of all known 
protein sequences can have their structure predicted via homology modeling efforts.54 
Schafferhans and Klebe found that accuracy increases when the results of several 
different homology modeling programs are combined.55 While predictive models are not 
as accurate as structures solved by x-ray crystallography or NMR, they enable the study 
of targets that are difficult to determine experimentally. No consensus has been reached 
on the best source of data for including structural flexibility in SBDD, and a number of 
studies clearly demonstrate the difficulty and variability in assessing appropriate 
conformations.56-60 
 
The following sections are organized based on different techniques for including 
protein flexibility in docking and de novo design (Table 1-1). Soft docking allows limited 
discovery of new conformation space while docking with flexible side chains (SC-Flex) 
samples observed conformational space. More recent techniques incorporate ensembles 
of structures to allow for a greater measure of native flexibility or to reveal new 
conformations. By relying on several protein conformations, new chemical space can be 
explored, allosteric sites can be discovered, and more accurate binding conformations can 
be generated. The accepted metric for a well-docked pose is ≤ 2.0 Å RMSD from the 
experimentally determined structure. Protein flexibility can be incorporated into a 
binding-site model before docking is initiated or it can be allowed post-docking through 
refinement of the bound complex. Docking can be performed against an average structure 
or ensemble, a series of rigid-receptor conformations (semi-flex), or with conformations 
generated “on the fly” (induced-fit docking, IFD).  
 
 
 
 11 
 
Table 1-1: Techniques for incorporating full protein flexibility into docking approaches. 
Approach Method for incorporation Advantages Limitations 
Refinement 
Flexibility introduced after 
docking through reduced or 
all-atom modeling with 
molecular dynamics or Monte 
Carlo minimization. 
Fast docking to rigid 
receptor enables 
searching through 
vast compound 
libraries 
Unlikely to generate as 
much structural 
diversity as the other 
methods, hard to 
move beyond known 
binding space 
Average or 
unified 
structure 
Ensemble averaging through use 
of a unified structure or grid 
representation. Can also 
occur through the selection of 
conformational subsets from 
a rotameric library, May also 
involve generation of 
receptor conformations based 
on ligand poses. 
Can find novel binding 
mechanisms, orphan 
sites, and explore 
new receptor 
conformations 
Discovery of 
“paradoxical 
inhibitors” that bind 
only to averaged 
conformation but not 
a native structure 
Serial docking 
Docking performed iteratively 
to a rigid ensemble of 
structures, conformational 
variation of the receptor 
ensemble typically comes 
from the inclusion of several 
X-ray crystallography, NMR, 
homology model, PCA-
derived, NMA-derived or 
MD-derived structures. 
Can allow for discovery 
of novel binding 
modes 
Ensemble generation 
and parallel docking 
can be time-
consuming, not 
usually appropriate 
for screening large 
libraries 
Structural variation can 
increase false 
positives 
Conformations 
on the fly 
Receptor conformational 
changes are explicitly 
modeled during docking. 
Allows receptor 
conformation to 
change during 
interaction with 
ligand for optimal 
binding, can be quite 
accurate 
Can generate 
conformations that 
are not 
experimentally 
accessible 
Can be quite time-
intensive, not 
necessarily 
appropriate for virtual 
screening 
 
Experimental methods for SBDD inherently include protein-ligand flexibility. 
However, lead development and design that is based solely on experimental data for 
ligand binding can be time-consuming and prohibitively expensive since every lead 
optimization step must be tested. Fragment-based drug design (FBDD) has enabled the 
application of experimental methods to searching the interaction potential along the 
protein surface with small organic probes. The use of fragment-based studies to SBDD 
enables the identification of ligands with high affinity for targets that have been 
traditionally difficult to characterize. These insights have greatly influenced 
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computational approaches to protein flexibility, where fragment mapping can be applied 
to flexible receptors with functional group probes to find binding hot spots and identify 
specific interaction potentials. The use of molecular dynamics and/or probe 
minimizations to search for important binding sites with small probes has frequently 
applied in SBDD projects because the results enable the development of a 
pharmacophore model for use in virtual screening studies. 
 
1.5.3. Early Protein-Ligand Flexibility in Docking 
Soft Docking 
It was not until the mid-90s that researchers began to tackle the problem of receptor 
degrees of freedom in SBDD. The original technique involved soft docking, which 
accounted for minimal backbone movement, and side-chain flexibility through 
attenuation of the Lennard-Jones repulsion term between the rigid protein and ligand.61 
This allowed for some penetration between the ligand and protein, and was followed by a 
rigid-body minimization. Soft docking increased the number of high scoring hits 
compared to the use of a single structure for docking. A study of T4 lysozme and aldose 
reductase showed that soft docking was superior to docking to a static structure.62 
However, the authors also found that serial docking to rigid receptors in a structural 
ensemble identified six novel compounds that soft docking had ranked poorly. Of these 
six compounds, four were experimentally verified and one had a low micromolar IC50 
value. 
Soft docking is a fast and easy method for including some protein flexibility into 
docking studies, and as a result is it included as a step in many of the methods presented 
below. 
Relaxation Methods 
Refinement of the docked complex is another simple approach that adjusts for protein 
flexibility by modeling induced-fit effects. The incorporation of protein flexibility on the 
“back end” can only be done when the docking technique was based on an all-atom 
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structure; it cannot be performed on a grid, or in any other situation where the protein is 
not explicitly represented. MC or MD simulations are a popular choice for refinement 
because they enable the optimization of docked poses investigation of solvent effects, 
examination of kinetic stability, and prediction of ΔGbind from physics-based scoring 
functions. Refinement is frequently performed as a final step in many of the docking 
approaches discussed here; Table 1-2 lists protein-ligand docking methods that limit the 
inclusion of full flexibility to the refinement stage.63 
 
Table 1-2: Studies including full receptor flexibility after docking. 
Method Target Flexibility Results Caveats Author 
FDS 
15 cases 
from 
GOLD 
test set 
Rigid-pro directed 
by hydrogen 
bonding  
Results clustered 
(clique finding 
technique), ~5 
poses subjected 
to SC-Flex via 
MC with 
GB/SA, soft 
potential, & SA 
Rigid-pro reproduced exp. 
pose for 13 cases 
Refinement with SC-Flex 
reproduced exp. pose for 
11 cases  
Accounted for continuum 
solvation 
For full-flex, RMSD of pose 
closest to crystal 
conformation (majority 
ranked 1) was 0.78 to 3.81 
Å to the crystal structure 
No 
consideratio
n of the 
effects of 
bound water 
Minimal 
conformatio
n change  
Required 30-
40 hours for 
a single run 
Taylor et 
al, 2003 
ADAM/ 
BLUTO 
18 cases 
for native 
docking; 
22 for 
cross 
docking 
Docked to binding 
site as vdW-
offset grid 
Post-docking 
optimization of 
ligand and 
protein side 
chains (within 
7 Å) of the 
binding site 
Top-ranked poses for 
thymidine kinase from 
ADAM/BLUTO were 
more accurate (RMSD 
0.52-1.89 Å) than rigid 
docking results from 
GOLD (RMSD 0.49-3.11 
Å), DOCK (RMSD 0.82-
9.62 Å), Surflex (RMSD 
0.74-3.84 Å), Glide 
(RMSD 0.35-4.22 Å), 
FlexX (RMSD 0.78-13.30 
Å), and ADAM (RMSD 
0.49-3.11 Å) 
RMSD of top-ranked model 
for all cases from 
ADAM/BLUTO ranged 
from 0.43 to 2.66 Å for 
cross-docking 
RMSD of top-ranked model 
for all cases from ADAM 
alone ranged from 0.67 to 
6.31 Å for cross-docking 
Most relevant 
for studying 
local 
changes in 
binding site 
conformatio
n 
  
Mizutani 
et al., 
2006 
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AMMOS 
Estrogen 
Receptor, 
Neur-
amindase 
Five options to 
refine docked 
complex, from 
full to zero 
protein 
flexibility 
Minimized results 
and reranked 
Assessed impact 
of AMMOS 
force field 
minimization 
vs. MM94 and 
Tffs on results 
for four known 
ligands 
Initial docking in DOCK6 
RMSD of refined structure to 
the crystal conformation 
ranged from 1.03 to 2.12 
Å for AMMOS, 1.01 to 
2.39 Å for MMFF94s, 
1.17 to 1.57 Å for Tff 
Enrichment increased by 
AMMOS refinement from 
40% to 60% overall, with 
actives retrieved from the 
top 3-5% of the data set 
Extent of 
minimizatio
n was very 
limited 
(2x500 
cycles) 
Only identifies 
minor con-
formational 
shifts 
Pencheva 
et al., 
2008 
Enhanced 
molecu-
lar 
docking 
Human 
prion 
protein 
Used 
metadynamics 
to refine 
docked 
complexes 
Calculated dissociation ΔG 
was 7.8-8.6 kcal/mol while 
experimental dissociation 
ΔG was 7.5 kcal/mol 
Predicted multiple binding 
sites 
Affinities agreed with NMR 
experiment 
Computation-
ally 
intensive 
Kranjc et 
al., 2009 
 
1.5.4. Docking with Flexible Side Chains  
Early efforts at “on the-fly” docking focused on the side chains, with the use of a 
rotamer library based on backbone dihedral angles to describe protein flexibility. In 1993, 
rotamer libraries were first used to predict side-chain conformations while studying the 
protein folding problem.64 In 1994, the use of side-chain rotamer libraries was extended 
to protein-ligand docking with the examination of trypsin-benzamidine and antibody 
McPC 603-phosphocholine binding through a modified version of AMBER 4.0.65 The 
study restricted the protein backbone completely while the side chains within 10 Å of the 
ligand were allowed to sample a set of discrete rotameric states. Leach found that the 
presence of the ligand revealed additional accessible conformational states by modulating 
the protein’s potential energy surface.  
Similar side-chain only methods for modeling protein flexibility in docking are 
presented in Table 1-3, including AutoDock 4.066, Dynasite/GOLD67, FlexX68, 
ICM/MC69, Mining Minima70, Skelgen71,72, SLIDE73-75, and SOFTSPOTS/PLASTIC76. 
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Table 1-3: Studies based on SC-Flex. Caveats for each method are similar in that flexibility of the side 
chains alone has limited success in describing receptor motion for most binding events. 
Method Target Flexibility Results Author 
Rotamer 
Library 
Trypsin, 
McPC 603 
Rotameric states sampled 
for all side chains within 
10 Å of binding site  
Limited by the lack of a 
solvation term 
RMSD of closest structure to the 
bound pose from the crystal 
was 0.7 Å for trypsin, 0.8 Å 
for McPC 603 
Leach, 
1994 
ICM/MC 
Leucine 
zipper 
helices 
Applied internal 
coordinated modeling 
(ICM) and MC 
minimization to all side 
chains at 600K 
Lowest energy conformation of 
leucine zipper had RMSD of 
1.18 Å to crystal pose 
Abagyan et 
al., 1994 
FlexX 19 cases 
Greedy incremental 
construction of the 
ligand into the active 
site from base ligand 
fragment 
RMSD of pose closest to crystal 
conformation (majority 
ranked 1) ranged 0.48 to 1.20 
Å 
Rarey et 
al., 1996 
SOFT 
SPOTS/  
PLASTIC 
Thymidylate 
synthase 
Identified variation based 
on structural comparison 
(or binding site analysis) 
Disregarded polar residues 
Retained hydrophobic 
residues and loops for 
potential adaptation 
Subjected 3 residues to 
rotamer variation 
Minimized docked pose 
Minimized, remodeled complex 
achieved reasonable energy 
scores for two potent 
inhibitors  
Found -51.5 kcal /mol for ligand 
BW1843U89 and -49.7 kcal 
/mol for CB3717 for cross-
docking with SC-Flex 
Found -32.8 kcal/mol for 
CB3717 and -44.7 kcal/mol 
for BW1843U89 with rigid-
pro 
Scores from native docking were 
-56.5 kcal/mol for 
BW1843U89 and -52.9 
kcal/mol for CB3717 
Anderson 
et al., 2001 
Mining 
Minima 
Set of 18 
protein-
ligand 
crystal 
structures 
On-the-fly optimization of 
the 5 nearest side chains 
(to the x-ray ligand) or 
hydroxyl-only 
hydrogens on the fly 
Three docking runs per 
system 
Native docking 
RMSD from SC-Flex of lowest 
energy pose ranged from 0.34 
to 2.32 Å to the crystal 
orientation for 8 known cases 
SC-Flex improved accuracy 
relative to rigid-pro for 4 
cases while it diminished 
accuracy relative to rigid-pro 
for the other 4 
SC-Flex highlighted important 
SC movement in hypothetical 
protein case 
Kairys & 
Gilson, 
2002  
Skelgen 
MMP-1, 
Acetylcholin
-esterase 
Random transitions of side 
chain χ angles were 
found to be preferable to 
a rotamer library due to 
the variation in 
composition & 
SC-Flex RMSD of pose closest 
to crystal conformation 
(majority ranked 1) were 1.0-
1.3 Å (native), 1.3-1.4 Å 
(non-native), 1.4 Å (apo)  
Rigid-pro RMSD of pose closed 
Alberts et 
al., 2005a  
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construction of rotamer 
libraries   
to crystal conformation 
(majority ranked 1) was 0.7-
1.0 Å (native), 4.4-4.5 Å 
(non-native), 5.6 Å (apo)  
SLIDE 20 cases 
Ligand anchor fragment, 
induced fit ligand/side 
chain rotation based on 
mean field theory 
Binding site represented as 
interaction points 
Docked to the apo pose 
Included active site 
solvation 
Minimal rotation 
hypothesis: side chains 
will move as little as 
necessary to form 
complex 
RMSD was ≤ 2.5 Å to the 
crystal orientation for all 
known ligands  
Specifically intended for systems 
without large global 
rearrangements (required apo 
to holo RMSD of ≤ 0.5 Å) 
Zavodszky 
et al., 2005 
AutoDock 
4.0 
188 native 
cases, 87 
HIVp cross-
docking 
cases 
Selected side-chain 
flexibility, receptor 
represented as a grid  
SC-Flex docked small native 
molecules well 
SC-Flex successful for most 
large inhibitors of HIVp, 
failed relative to rigid-pro for 
small inhibitors >50% of the 
cases (3.5Å) 
Morris et 
al., 2009 
 
Allowing side-chain flexibility was less resource intensive than full flexibility 
methods and it enabled some conformational variability through the exploration of low 
energy orientations of side chains. However, incorporating side-chain flexibility has 
failed in cases of proteins with large-scale hinge or loop rearrangements or even 
backbone-dependent movement of side chains, neither of which can be taken into account 
by SC-Flex. 
 
1.5.5. Induced Fit Docking 
Conformational generation on the fly 
Significant progress has been made since the initial development of SC-Flex. 
Sampling motion of the side chains “on the fly” increases the potential energy space but 
can still overlook global conformational shifts. Allowing for conformational changes “on 
the fly” during docking can be a highly accurate technique for modeling bound poses of 
protein-ligand complexes. Induced fit docking (IFD) is important because it can allow the 
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docking simulation to search new conformational space, however this sampling of 
receptor and ligand degrees of freedom is also quite computationally intensive, which 
limits its application in large-scale virtual screening studies.  
The first “on the fly” method that expanded beyond conformational sampling of side 
chains was based on DOCK 4.0.77 The authors included the conformational ensemble as 
an adjustable variable in the IFD algorithm as opposed to performing serial docking 
across an entire ensemble. In addition to the usual six degrees of freedom for ligand 
flexibility, the authors added a protein conformation term, which allowed the protocol to 
simultaneously optimize the ligand conformation and choose the best protein structure for 
binding. Ten separate protein ensembles were used for development and were obtained 
from the set by Cavasotto and Abagyan78, the set by Claussen et al.79, and two HIV-1 
protease (HIVp) ensembles. They achieved a success rate of 93% when the five highest-
ranked poses were included using a threshold for success of 2.5 Å RMSD from the 
experimental pose. Their method ran for a similar amount of time as rigid-pro and was 
significantly faster than traditional techniques for serial docking to rigid receptors. Other 
IFD methods for including protein flexibility include 4D Docking80, FITTED81-83, 
GLIDE/PRIME84,85, PC-RELAX86,87, REMD/PLOP88, and SCaRE89, as presented below in 
Table 1-4. 
 
Table 1-4: Docking studies that utilized full receptor flexibility during the performance of IFD. 
Method Target Flexibility Results Caveats Author 
GLIDE/ 
PRIME 21 cases 
Soft-potential docking 
to RR  
Ala replacement ≤ 3 
residues 
Top 20 complexes 
refined & redocked 
Avg RMSD = 5.5 Å 
for rigid-pro, 1.4 
Å for IFD  
Very time 
intensive, 
limited to local 
motion  
Sherman 
et al, 2006 
Conform-
ational 
ensemble 
as 
docking 
variable 
10 cases 
Conformational 
ensemble included 
as a variable during 
docking with 
DOCK4.0 
Selected each 
representative side 
chain within the 
active site based on 
which had the 
greatest distance 
from the reference 
Ensemble docking 
was the same 
speed as rigid-pro 
Ensemble docking 
had 67-100% 
success based on 
pose and score 
Rigid-pro had 23-
87% success in 
cross-docking 
based on pose and 
score 
Use of a unified 
representation 
of the receptor 
can result in 
the 
identification 
of high-scoring 
false positives 
Huang 
and Zou, 
2007 
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sphere points from 
SPHGEN 
Bound complex was 
optimized with 
SIMPLEX 
Success defined as 
RMSD from crystal 
pose of ≤ 2.5 Å and 
an energy score > 
the native docking 
Sequential rigid-pro 
had 33-100% 
success based on 
pose and score 
SCaRE 
16 cross-
docking 
pairs 
Optimal results with 
Ala replacement of 
2 neighboring side-
chain pairs  
Ligand docked to 
gapped 
conformation 
Clustered, optimized, 
and refined 
complex with 
original side chains 
With pocket 
boundaries equal 
to all residues ≤ 5 
Å from the ligand, 
best RMSD for a 
docked pose to the 
crystal structure 
(with majority 
rank 1) was 0.7-
2.0 Å (90% 
success) 
Rigid-pro 50% 
success rate 
Limited view of 
active site 
flexibility 
Time consuming 
Bottegoni 
et al., 
2008 
PC-
RELAX 
set of 
CDK2 
structures 
PCA/ANM-derived 
soft mode docking 
with no flexibility, 
side chain 
flexibility, 
backbone 
flexibility, or full 
flexibility 
Starting with apo 
structure, found 
best RMSD to the 
crystal structure of 
0.8-1.8 Å (rank 
ranges 1-9) for 
fully flexible 
versus 0.5 to 5.2 Å 
(rank ranges 1-18) 
for rigid-pro 
Time intensive 
relative to 
rigid-pro, 
cannot capture 
highly flexible 
motion 
May & 
Zacharias 
2008 
 
REMD/ 
PLOP 6 cases 
REMD used to 
generate low 
energy loop 
conformations 
After clustering, loops 
refined with PLOP 
Lowest energy 
conformer used for 
docking with 
GLIDE 
RMSD of docked 
pose between holo 
and predicted 
structure was 1.4-
12.5 Å 
RMSD of docked 
pose between holo 
and crystal 
structure was 1.0-
2.5 Å 
RMSD of docked 
pose between holo 
and apo structure 
was 1.8-13.2 Å  
Limited by 
efficiency of 
REMD for 
generating 
loop 
conformations 
Wong & 
Jacobson, 
2008 
FITTED 
2.6 
5 protein-
ligand sets 
Modified GA for 
receptor 
chromosome  
Allowed switching 
between 
conformations, side 
chains in the 
binding site, and/or 
Success rate based on 
RMSD of docked 
pose to crystal 
structure was 79% 
for native rigid-
pro, 56% for 
cross-docking 
rigid-pro, 67% for 
Flexible docking 
was unable to 
select the exact 
experimental 
complex 
structure 
While 
computational 
Corbeil et 
al., 2009 
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water positions 
Can perform rigid-pro, 
semi-flex, or full-
flex  
 
SC-Flex, and 67% 
for flexible 
docking 
Notable speed 
increase over 
previous versions 
speed 
increased, 
accuracy 
decreased 
between 
FITTED 1.5 
and 2.6 
4D 
Docking 
267 
nonredun-
dant 
structures 
Ensemble assembled 
onto 4D grid based 
on binding 
potential and 
superposition 
During docking, could 
switch receptor 
conformation as 
well as ligand 
conformation 
4D docking 73% 
success rate  with 
3-8 conformers 
when cognate 
receptor wasn’t 
included 
For the same 
scenario, semi-
flex had 71.1% 
success rate 
4D docking was 4x 
faster than semi-
flex 
 
Performance 
decreased with 
> 8 conformers 
4D docking 
marginally less 
successful than 
semi-flex 
Bottegoni 
et al., 
2009 
 
1.5.6. Ensemble Docking 
Ensemble docking differs from IFD in that protein flexibility is accounted for prior to 
the actual docking. Although the studies by Huang and Zou90 as well as Bottegoni et al.80 
used a pre-existing ensemble of conformations, they sampled those conformations on the 
fly, and so they are included above in the IFD section. Two different types of methods 
exist for representing receptor flexibility during docking: grid-based ensembles and 
structure-based ensembles. Frequently, alternate protein conformations are represented on 
a two-body potential grid, enabling fast, inexpensive docking simulations. Flexibility can 
also be incorporated into binding predictions through the sequential docking to structures 
in a conformational ensemble or docking to an averaged/united receptor structure. Due to 
the time required for initial ensemble generation and repeated rigid-pro, sequential 
docking is typically the most computationally intensive approach. However, it avoids the 
discovery of receptor-ligand complexes that are physically impossible (paradoxical 
ligands), which are sometimes seen in the results from docking to an average structure. 
Grid-based ensembles 
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The first docking method to use a composite grid was performed through DOCK3.5 
in order to evaluate the impact of representing conformational variability as a structural 
ensemble on binding pose results.91 With HIVp, ras p21, retinol binding protein, and 
uteroglobin as their test cases, the authors compared the capacity of standard grids to 
energy- and geometry-weighted average grids to reproduce known binding poses and 
affinities. They found that docking scores were sensitive to the grid spacing and threshold 
parameters used to define the composite grid. The performance of the geometry-weighted 
grid was less dependent on the protein conformations that were available than the energy-
weighted, to the extent that the geometry-weighted grid placed known ligands for HIVp 
was within the top 21%, while the energy-weighted grid placed them in the top 33%. This 
occurred because the geometry-weighted grid ignored the repulsive potentials between 
flexible atoms, while the energy-weighted grid simply smoothed the repulsive potential, 
which can result in the retrieval of paradoxical inhibitors.  
The multiple copy simultaneous search (MCSS) methodology was the earliest 
computational approach for mapping binding sites with functional group probes.92 The 
authors simultaneously minimized or quenched the probes by MD to the binding site of 
the hemagglutinin protein to identify favorable minima and found some correspondence 
between the positions of the minima and the functional groups on the ligand, sialic acid. 
While the authors noted that their method could account for a limited amount of side 
chain flexibility by including multiple copies of the side chains, the published work was 
performed against a rigid structure.  
Stultz and Karplus explored the influence of protein flexibility on the results from 
grid-based MCSS where five different protocols for placing two functional group probes, 
methanol and methyl ammonium, were used to search the binding surface of HIVp.93 
MCSS calculations were performed for 1: a minimized crystal structure, 2: a 
conformation generated from quenched MD of the initial structure, 3: an unrestrained 
structure, 4: the output of 1 subjected to quenched MD with functional groups restrained 
and multiple side-chain copies, and 5: a different rigid crystal structure of HIVp. The 
authors found that their results with protocols 4 and 5 yielded more favorable interaction 
energies than the reference protocol 1. Protocol 4 gave valuable information for ligand 
design, while the different low-energy minima from protocol 5 supported the idea of 
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performing MCSS against an ensemble of structures and comparing the results, therefore 
the authors suggested a combination of 4 and 5. However, one of the limitations of 
MCSS and other grid-based methods is that they do not account for entropy or solvation 
during surface mapping, which hampers discrimination between druggable and irrelevant 
minima. Furthermore, as Schubert and Stultz point out in their review of MCSS, 
functionality maps are difficult to combine across different structures of a protein.94 
The incorporation of protein flexibility through docking to an interaction grid that 
represents the receptor ensemble is a common approach for SBDD, and additional 
methods are presented in Table 1-5, including those based on AutoDock 3.095, Flog96, 
GRID/CPCA97, IFREDA78, ISCD98, and sets of consensus structures99. 
 
Table 1-5: Studies including full receptor flexibility through grid-based ensemble docking. 
Method Target Flexibility Results Caveats Author 
DOCK3.5 
composite 
grids 
4 cases 
Geometry-averaged 
and energy-
weighted grids 
Geometry-averaged 
grids gave results 
that were less 
influenced by input 
conformation 
Geometry-weighted 
average grid yielded 
RMSD of 0.4-1.6 Å 
Energy-weighted 
average found 
RMSD of 0.4-4.0 Å 
Recovers local 
minima in 
addition to 
the binding 
site 
Can identify 
paradoxical 
inhibitors 
Knegtel et 
al., 1997 
Grid-
based 
MCSS 
HIVp 
Used quenched MD 
to generate new 
conformations or 
mapped a 
different 
conformation 
from the 
reference 
Local optimization of 
selected probes from 
MCSS improved 
interaction energy 
Protocols 2 and 3 
yielded functionality 
maps that were the 
most divergent from 
the reference  
Protocol 4 yielded the 
most low-energy 
minima 
Recovers local 
minima in 
addition to 
the binding 
site 
Very minor 
amount of 
protein 
flexibility 
included 
Stultz and 
Karplus, 
1999 
GRID/ 
CPCA 
3 serine 
proteases 
Docking performed 
to crystal 
structures with 
GRID 
Used a scaling 
weight to 
normalize the 
probes 
Consensus PCA 
Validated as a potential 
tool for enhancing 
ligand selectivity to a 
specific target 
Able to predict 
important cation-π 
and hydrophobic 
interactions 
Highlighted ways 
Contour plots 
Only gives 
probe 
position, not 
orientation 
Kastenholz 
et al, 2000 
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gave contour 
plots of MIF 
enzyme selectivity 
could be 
incorporated in 
ligand design 
Flog 
L. casei 
DHFR, 
murine 
COX2 
Used snapshots 
from short MD 
for averaged grid-
based docking 
Used SIMPLEX 
optimization of 
the ligand in the 
binding site 
Calculated binding 
energy with post-
docking MD free 
energy 
perturbation 
Weight-averaged grids 
performed better 
than the grid of the 
average or static 
crystal structure, 
selecting 8 leads 
within the top 1% of 
the database, 
compared to 6 leads 
(crystal) or 7 leads 
(average) out of the 
16 possible leads 
Average and weight-
averaged grids 
required less than 
half the CPU hours 
with optimization 
than using the crystal 
structure grid  
Automated 
process, 
likely to 
result in 
incorrect 
results for 
certain 
complexes 
Could identify 
paradoxical 
binders 
Broughton 
2000 
AutoDock 
3.0 
HIVp 
(21) 
Combined multiple 
receptor 
conformations 
onto interaction 
energy grid 
Compared mean, 
minimum, 
clamped, and 
energy-weighted 
grids 
Retained structural 
waters during 
docking 
RMSD in energies was 
1.34 kcal/mol for 
clamped, 1.43 
kcal/mol for energy 
weighted, 7.69 
kcal/mol for mean, 
6.07 kcal/mol for 
minimum grids 
Weight-averaged grids 
performed best, 
retrieving the correct 
conformation 87% of 
the cases 
Limited ability 
to map 
conformation
al shifts 
Could identify 
paradoxical 
binders 
Osterberg 
et al, 2002 
IFREDA 
PK (33), 
1000 
compoun
d virtual 
screen 
Multiple conformers 
generated by 
repeated flexible 
docking with 
known ligands 
Serial-dock used for 
screening  
Average accuracy of 
70% in cross-
docking with a 
threshold of 2.5 Å 
De novo structure 
generation for eight 
complexes found that 
most of the lowest 
energy ligands were 
within 2 Å of the 
native state 
Unable to map 
backbone 
shifts 
Inadequate 
solvation 
model 
 
Cavasotto 
& 
Abagyan, 
2004 
ISCD 
Aldose 
reduct-
ase, 
throm-
bin, 
trypsin 
Three single 
confomer grids 
were joined 
Repulsive layers 
between the 
individual grids 
Top 15 ranked ligands 
had an RMSD to the 
crystal structure < 
1.4 Å for aldose 
reductase 
Joined grids for 
thrombin and trypsin, 
docking found that 7 
Limited 
capacity for 
structural 
ensemble 
Could identify 
paradoxical 
inhibitors 
Zentgraf et 
al., 2006 
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of 9 ligands 
preferentially docked 
to thrombin (cluster 
rank 1) 
The other 2 ligands 
were selective for 
trypsin and bound 
trypsin (cluster rank 
1) 
Computationally 
inexpensive relative 
to typical ensemble 
docking 
Consensus 
structures 
HIV-RT 
(47) 
Normalized B-
factors, ligand-
induced 
displacement, and 
consensus grids 
represented 
binding cavity 
Identified 2 novel 
interaction sites  
Results supported by 
experimental work 
by Sweeney et al., 
2008 
Proposed combining 
theories of NNRTI 
activity 
Requires 
available 
experimental 
structural 
information 
for consensus 
calculation 
van Westen 
et al., 2010 
 
Structure-based ensembles 
The original technique for structure-based ensemble docking was introduced by 
Carlson et al. as the dynamic pharmacophore model100, later termed the multiple protein 
structure, MPS, method.101 Two pharmacophores for HIV integrase were generated, a 
static model based on a rigid crystal structure and a dynamic model based on MD 
snapshots initiated from the same crystal structure. The MPS method mapped the 
dynamic binding surface of the protein with common functional groups by running a 
series of multi-unit search for interacting conformers (MUSIC) simulations (Figure 1-3), 
wherein hundreds of probes were used to flood the protein surface and then minimized by 
Monte Carlo (MC) sampling. During MUSIC simulations, all of the probe-probe 
interactions were ignored, which allowed probes to interact with the rugged binding 
potential of the protein and cluster into hot spot positions along the protein surface. These 
cluster sites were used to develop a pharmacophore for virtual screening, and where the 
rigid model was unable to locate any of the test case inhibitors, the dynamic 
pharmacophore model not only identified known inhibitors, but it also predicted new 
inhibitors that were confirmed by experiment. The MPS method is one of the few 
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ensemble-based methods that has been successfully used to find novel leads with 
demonstrated activity.102,103 
 
Figure 1-3: MUSIC simulations of benzene probes (gray) to the surface of a HIVp monomer (purple). Five 
hundred probes were flooded onto the protein surface, minimized, and then clustered together. Parent 
probes were identified for each monomer conformation, the HIVp monomers were aligned through a 
weighted-RMSD function, then the parent probes were clustered together and retained when at least half of 
the protein conformations contained a probe at that site. This resulted in low-energy probe clusters 
(colored red through purple) of benzene that could be combined with ethane and methanol clusters to 
develop a pharmacophore model. 
McCammon and co-authors developed the relaxed complex scheme (RCS) as a 
technique for incorporating receptor flexibility prior to docking.104-106 Initially the method 
was developed to generate conformational ensembles of the apo state through MD, which 
were then used in AutoDock to screen compound mini-libraries and score the receptor-
ligand complexes. The 2003 study by Lin et al. examined FKBP-12 by RCS and 
implemented a final refinement step with MM/PBSA107 to yield final results. Further 
updates to this method have included extension to virtual screening and reduction of the 
conformational ensemble to a representative configurational set108. RCS was successfully 
used to identify cryptic binding pockets and/or lead inhibitors of HIVp109, avian influenza 
neuraminidase110, acetylcholine binding protein111, DNA polymerase β112, 
MDM2/MDMX113, and cruzain114.  
RosettaLigand was introduced as an extension of the protein-protein docking 
program, RosettaDock.115 In the 2006 paper, side chains were repacked during docking 
through the implementation of a rotamer library while the vdW repulsion term was 
softened and ligand conformations were perturbed with MC. Their benchmark set 
included 100 complexes for native and 10 for cross-docking. They found a success rate of 
80% for native docking and 70% for cross-docking. The initial reliance of RosettaLigand 
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on side-chain motion as the only representation of protein flexibility was altered by the 
inclusion of full receptor flexibility obtained from multiple crystal structures.116,117 
Although RosettaLigand has generated good results, with protein flexibility included it 
requires 40-80 processor hours to generate a bound pose for the receptor-ligand complex 
and therefore is too time-consuming for use with large compound libraries.  
To determine the best process for developing a structural ensemble, Rueda et al. used 
ICM to examine the same set of 1068 conformations from 99 pharmaceutically-relevant 
proteins that was used in the 4D docking study.118 The authors judged performance in 
virtual screening based on the “area under the ROC plot curve” (AUC) and found that 
holo conformations yielded improved AUC values compared to apo conformations. It 
was interesting that the authors found that ensembles of holo plus apo conformations did 
not significantly improve results compared to holo-only ensembles. In cases without a 
holo structure, the authors recommended the use of an apo structure with the largest 
pocket volume. The authors proposed the use of a ligand-guided approach to find the 
optimal protein conformation, but stated that docking to an ensemble would be an 
acceptable substitute in the absence of ligand activity data. Several groups have found 
that there tends to be a single receptor conformation that grants the best performance in 
docking studies.118,119 
Normal mode analysis (NMA) has been frequently used as a tool for examining 
protein flexibility relevant to ligand binding.74,86,87,120-125 It is important to note that low-
frequency modes identify large-scale motions, while high-frequency modes identify 
small-scale motion. Rueda et al. showed that they could use NMA on elastic network 
models for all heavy atoms of the receptor in order to derive an ensemble of protein 
conformations and improve results from rigid-pro cross-docking in ICM.126 Fourteen 
proteins, each with two structures and their cognate ligands, were used as the benchmark 
test set. Optimal results involved the generation of 100 different conformations from 
NMA on all heavy-atoms within 10Å of the ligand-binding site. Larger conformational 
ensembles, such as those with 200 members, negatively affected false positive rates. 
Another NMA-based method for conformational selection was based on cyclin dependent 
kinase-2 (CDK-2), because it had a sufficient amount of available experimental data on 
ligand binding for validation of the NMA protocol.127 Unlike most other NMA-based 
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methods, the authors included all of the protein atoms in the calculation in order to better 
represent conformational changes and found that too many protein conformations 
negatively impacted docking results through the recovery of false positives.   
Of the variety of techniques that have been developed to improve binding predictions 
for protein-ligand complexes, the use of a conformational ensemble is perhaps the most 
common approach. Representative cases and novel methods based on structure-based 
ensemble docking are listed in Table 1-6 and include modifications to DOCK128, docking 
to a large set of conformations119,129, NMA and MD-based approaches125,130-132, structure 
prediction133, the ensemble reduction method134, F-DycoBlock135, FIRST136, 
FIRST/ROCK/SLIDE137, Fleksy138, FlexX-Ensemble79,139, FlipDOCK140,141, Flo98142, 
MCSA-PCR143, MD+LigBuilder144,145, PhE/SVM146-148, QSiCR149,150, a reduced receptor 
ensemble151, Skelgen152, and Surflex153-155. 
 
Table 1-6: Studies including full receptor flexibility through a structural ensemble for docking.  
Method Target Flexibility Results Caveats Author 
FlexX-
Ensemble 105 cases 
Averaged highly 
conserved regions 
Retained 
orientations of 
flexible regions as 
a set 
FlexX-Ensemble 
yielded 66.7% 
success (40 hits) 
compared to 63.3% 
with FlexX within 
an RMSD of < 2 Å 
for the first 10 
solutions 
May find ligands 
that are not 
compatible 
with the “real” 
ensemble 
May not identify 
the lowest 
RMSD 
complex 
Claussen et 
al., 2001 
MCSA-
PCR 
Major 
histocomp
atibility 
complex 
Ligand grown into 
binding pocket 
with each SA 
cycle 
Generated pseudo-
crystallographic 
density map 
Identified optimal 
ligand position and 
important waters 
based on simulation 
density  
Side-chain RMSD of 
VSV8 peptides from 
explicit simulation 
was 2.15 Å for N/C 
termini-restraints, 
2.61 Å for Cα 
restraints, and 2.41 
Å for backbone 
restraints 
High 
computational 
effort, not 
suitable for VS 
Ota & 
Agard, 
2001 
F-Dyco 
Block 
HIVp, 
COX-2 
Split ligands into 
smaller building 
blocks 
Performed locally 
enhanced 
sampling and 
Recovered the ligand 
3/3 results for HIVp 
when full flexibility 
was allowed (except 
secondary-structure 
hydrogen bonds), 
Simple 
clustering 
Dependent on 
threshold 
value and 
cluster 
Zhu et al., 
2001 
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multiple-copy 
MD with a 
dynamic 
connecting 
algorithm 
Tested grid 
approximation & 
4 ways to manage 
receptor flexibility 
compared to only 
recovering the 
correct complex for 
1 ligand when 
backbone-flexibility 
was restrained 
Recovered the correct 
ligand in 7/76 
results for COX-2 
position 
MD+ 
Lig 
Builder 
Alanine 
Racemase 
Dynamic 
pharmacophore 
modeling similar 
to MPS, but can 
simultaneously 
search with 
multiple probes 
LigBuilder mapped 
surface properties 
of each 
conformation (11 
total) after MD  
Dynamic 
pharmacophore 
model identified 34 
hits out of the set of 
43 known binders, 
compared to the 27 
identified by the 
static model 
Very brief phase 
of MD for 
conformation 
generation 
Mustata & 
Briggs, 
2002 
RCS FKBP-12 
Conformations 
generated by MD 
Rapid docking in 
AutoDock 
Refinement of high 
scoring 
complexes with 
MM/PBSA 
Correctly ranked the 
crystallographic 
pose as the highest 
rank with 
MM/PBSA for all 
three cases 
Can be time-
consuming 
Short MD 
simulation 
(2ns) used for 
conformer 
generation 
Lin et al., 
2003 
Modified 
DOCK 
T4 
lysozyme 
mutant 
Calculated 
interaction energy 
between ligand 
and flexible 
regions 
independently 
Used results to 
create average 
receptor 
representation for 
VS 
Found 18 new hits 
Conformation’s 
internal energy 
important for final 
ranking 
Conformational 
ensemble retrieved 
approximately 79% 
of ligands in the top 
1.5% of the 
database, compared 
to the holo 
conformation 
retrieving 77% and 
the apo 
conformation 
retrieving 54% of 
the ligands 
Conformational 
changes 
caused by 
ligand binding 
not fully 
predicted by 
method 
Wei et al., 
2004 
FIRST/ 
ROCK/ 
SLIDE 
CypA, 
estrogen 
receptor 
Analyzed flexibility 
potential (FIRST) 
and sampled 
rotational bonds 
to generate 
receptor ensemble 
(ROCK) 
SLIDE accounted 
Representative 
ensemble similar to 
NMR structures 
Captured important 
hydrogen bonds 
present in the 
receptor-ligand 
complex 
Compared score 
distributions, 
no individual 
assessment of 
relative 
likelihood/ 
energy for 
generated 
Zavodszky 
et al., 2004 
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for side-chain 
flexibility and 
solvation 
 conformers 
Docking 
to a 
Structur-
al En-
semble 
Hsp90 
(57), 
CDK2 
(34) 
Compared full-flex 
to rigid-pro 
For Hsp90, the use of 
pharmacophoric 
restraints improved 
docking results, with 
multiple cavity 
docking having 86% 
average success 
compared to single 
cavity docking 
having 57% average 
success 
For CDK2, single best 
cavity gave 64% 
success, 6 best gave 
94%, entire 
ensemble gave 76% 
 
Incorrectly 
assumed 
negligible 
difference in 
conformational 
free energy 
Use of multiple 
cavities for 
virtual 
screening was 
limited by bad 
poses with 
good scores 
 
Barril & 
Morley, 
2005 
Low-
freq-
uency Cα 
NMA 
cAPK 
Kinase 
NMA generated 
alternative 
conformations 
based on 
relevance to loop 
plasticity 
Minimized side 
chains while 
bound to non-
native ligand 
Improved docking and 
enrichment scores 
relative to rigid-pro 
RMSD of the top 
ranked pose to the 
native pose was 0.6-
4.0 Å, with one 
outlier at 7.0 Å for 
docking to the NMA 
conformer and was 
0.4-10.2 Å for 
docking to the 
crystal structure 
Used known 
binders, 
potentially 
biasing 
available lead 
space 
Cavasotto 
et al., 2005 
Elastic 
Network 
Model 
6 protein-
ligand 
cases 
Low frequency 
NMA to optimize 
docked receptor-
ligand complexes 
and identify new 
conformational 
space 
Used eigenvectors 
of apo protein  
Improved the global 
coordinate RMSD 
by ≤ 3.2 Å to the 
predicted complex 
to the experimental 
pose 
Refinement with 
restraints on mode 
amplitude 
performed much 
better than MD or 
NM minimization, 
or unrestrained 
scanning 
Most successful 
for systems 
where 
flexibility can 
be represented 
well in only a 
few modes 
Lindahl & 
Delarue, 
2005 
Skelgen 
Estrogen 
receptor-α 
(7) 
De novo design 
through serial-
dock 
Ligands generated 
from fragment 
design 
Two different 
pharmacophoric 
Identified 4 novel lead 
compounds 
Best had IC50=340nm 
Dependent on 
pharmaco-
phoric 
constraints 
Time and 
material 
intensive 
Firth-Clark 
et al., 2006 
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constraints 
applied 
Selected top 25 
complexes for 
each constraint 
set, yielding 350 
compounds for 
testing 
Explicit 
solvent 
MD/ 
Auto 
Dock 
p38 
MAPK 
(5000 MD 
snapshots) 
Performed 3 
simulations of 60-
ns each with MD 
Used snapshots 
from MD 
simulation for 
docking with 
AutoDock 
Found 2 novel 
conformations of 
DFG motif 
Successfully docked 5 
known inhibitors 
Conformers from 
simulation identified 
cryptic binding sites 
Extensive MD 
simulation 
(390ns total) 
render this 
technique 
impractical for 
some SBDD 
applications 
Frembgen-
Kesner & 
Elcock, 
2006 
Flo98 
C. 
hominis 
DHFR, T. 
gondii 
DHFR 
SA of active site 
MC search for 
optimal bound 
pose 
Averaged energy of 
25 lowest energy 
protein-ligand 
complexes 
Developed 
homology model 
for TgDHFR 
Calculated binding 
affinity was 72.9% 
correlated to 
experiment 
(ChDHFR) 
Identified alternate 
binding site 
50.2% correlation 
between docking 
and activity 
(TgDHFR) 
Enabled limited 
flexibility of 
binding site 
residues only 
during global 
MC docking 
Popov et 
al., 2007 
PhE/ 
SVM 
Ether-à-
go-
go Related
 Gene 
Receptor flexibility 
through a 
pharmacophore 
ensemble from 26 
training set & 13 
test set 
compounds 
  
Potential to enable 
protein plasticity 
even when structural 
information is 
inadequate for other 
methods 
Can not identify 
large structural 
shifts 
 
Leong, 
2007 
Predict-
ive 
Model-
ing 
Androgen 
Receptor 
Predicted receptor 
conformation 
from backbone 
conformation 
Optimized side 
chains 
Repeated selection 
~15 times to 
discriminate 
agonist and 
antagonist bind 
Potentially identified 
drug repurposing 
candidates for 
antiandrogenic 
activity, based on 
cross-docking and 
competitive binding 
assays  
Time intensive 
Requires a priori 
knowledge & 
similar protein 
structures for 
initial 
predictive 
modeling 
Bisson et 
al. 2007 
Fleksy 35 cases 
Generated ensemble 
from soft potential 
backbone-
dependent rotamer 
exploration  
Used FlexX-
Ensemble with 
soft docking 
Flexible 
Successful flexible 
cross-docking for 
78% of the cases, 
compared to 44% 
success for FlexX  
(rigid-pro) 
Cannot handle 
large changes 
in backbone 
conformation 
No consideration 
of solvent 
effects 
Nabuurs et 
al, 2007 
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optimization of 
complex with 
Yasara 
Flip 
DOCK 
HIVp, 
Protein 
Kinase A 
Flexibility Tree data 
structure 
represented 
conformational 
subspace 
Enabled full-flex 
with AutoDock 
Divide-and-conquer 
GA yielded best 
results 
FlipDOCK 
outperformed rigid-
pro 93.5% to 72% in 
cross-docking 
Each degree of 
freedom must 
be selected by 
hand 
Zhao & 
Sanner, 
2007 & 
2008 
QSiCR 
CDK2, 
p38 
MAPK 
Used known binders 
to generate 
protein flexibility 
Built conformers 
from MACCS 
keys and 
topological details 
Average R2 = 0.73 for 
active site size and 
distances of CDK2  
Average cross-
validated R2 = 0.60 
for predicted 
backbone 
conformational 
changes of p38 
MAPK  
Does not fully 
represent 
available 
interaction 
space 
Highly 
dependent on 
ligand training 
set 
Subram-
anian et al. 
2006 & 
2008 
Reduced 
Receptor 
Ensemble 
Avian flu 
neuramind
-ase 
Similar to MPS 
Generated MD 
ensemble 
Flooded ensemble 
with probes (CS-
Map), created 
pharmacophore 
Predicted novel hot 
spots potentially 
relevant for de novo 
ligand design 
No experimental 
support of sites 
or energy 
ranking of 
fragment 
clusters 
Landon et 
al., 2008 
Ensemble 
Reductio
n Method 
DHFR 
Generated MD 
ensemble 
Used relative 
difference 
distance to define 
optimal 
conformations 
Conservation of 
essential distances 
between binding 
residues best for 
selecting 
representative 
ensemble 
Maintaining 
conserved core 
distances may 
limit 
exploration of 
important 
large-scale 
shifts 
Bolstad & 
Anderson, 
2009 
Rosetta 
Ligand 85 cases 
Included receptor 
flexibility through 
multiple 
conformations 
Average RMSD of 
pose closest to 
crystal conformation 
(majority ranked 1) 
ranged from 1.43-
2.44 Å for flexible 
backbone docking 
compared to 2.39-
2.49 Å for rigid 
docking to JNK3 
kinase and 
urokinase 
Not as easily 
applicable to 
virtual 
screening 
Davis et 
al., 2009 
EN-
NMA 14 cases 
Used NMA to 
generate 100 
distinct 
conformers for 
heavy atoms with 
10 Å of the 
binding site 
From NMA-based 
conformers, able to 
select 20 of 28 
cross-docking cases 
amount top 5 
The larger 
conformational 
ensemble of 
200 structures 
increased false 
positive rates 
Rueda et 
al., 2009 
Implicit 6 Protein Docked via 40 Best results: distance- One solvation Huang & 
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Solvent 
MD 
Kinases & 
Phosphat-
ases 
simulated 
annealing cycling 
simulations for 
each protein-
peptide complex 
Restrained protein 
Cα 
dependent dielectric 
solvation model 
docking & GB 
molecular volume 
scoring, based on 
total system energy  
model alone 
(GB molecular 
volume versus 
distance-
dependent 
dielectric) not 
always correct 
Wong, 
2009 
Surflex 
85 
cognate 
cases, 8 
cross-
docking 
cases 
Updated to allow 
structural 
ensembles and 
post-docking 
refinement 
Created idealized 
ligand to model 
active site 
Ligand built in 
through 
incremental 
construction/comb
ination 
61% success after 
docking, 67% after 
refinement and 
rescoring, 75% after 
using the best of 2 
pose families 
Moderate 
computational 
expense 
For some cases, 
ligand sub-
fragments 
guiding 
docking could 
have a 
negative 
impact  
Jain, 2009 
Docking 
to a 
Structural 
Ensemble 
BACE, 
cAbl 
Examined 
enrichment from 
ensemble docking 
compared to rigid-
pro for choosing 
the inhibitors over 
mimetic decoys 
Used five different 
strategies for 
combining 
receptor structures 
into an ensemble 
Docking performed 
in Glide 
Area-under-curve 
(AUC) for rigid 
BACE structures 
ranged from 0.688 
to 0.778 
Construction of an 
ensemble from 
receptors which 
demonstrated 
optimal rigid-pro 
success against 
different 
chemotypes yielded 
the best performing 
ensemble 
Technique was 
based on 
improving 
enrichment 
against known 
inhibitors 
rather than 
exploring 
conformational 
space 
Did not account 
for solvation 
or energy of 
the receptor 
Craig, et al. 
2010 
ICM 99 cases 
Studied the impact 
of using holo 
versus apo protein 
conformations for 
virtual screening 
based on AUC 
scores 
Found that there is one 
receptor 
conformation within 
the ensemble that 
gives the optimal 
performance 
Holo conformations 
outperformed apo 
conformations in 
most cases 
The authors 
noted that 
ensemble 
docking 
performed 
better than a 
single average 
structure, with 
0.88 ± 0.18 
mean AUC 
versus 0.78 ± 
0.22, but those 
ranges overlap 
significantly 
 
Rueda et 
al., 2010 
All atom 
NMA CDK2 
Used all of the 
protein atoms for 
conformational 
selection 
Pursued relevant 
Over all cases, 
successful docking 
occurred for 54.3% 
(holo crystal 
structure), 58.1% 
As seen in many 
of the 
ensemble-
based 
methods, care 
Sperandio 
et al., 2010 
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structures from 
the 20-25 lowest 
modes 
Required a deviation 
of at least 1 Å, but 
no more than 8 Å 
from the 
minimized crystal 
structure for new 
conformations 
(apo crystal struct-
ure) 42.8% 
(minimized apo 
crystal struct-ure) 
70.4% (best NMA 
structure) 55.7% 
(second-best NMA 
structure), and 
55.2% (third best 
NMA structure) 
was required 
in conformer 
selection to 
avoid 
discovery of 
too many false 
positives  
NMA is not 
applicable to 
small local 
motions or 
large domain 
shifts  
Explicit 
solvent 
MD/ 
Glide 
Reverse 
transcript-
ase 
(10,000), 
W191G 
(7,500) 
Generated 
conformational 
ensemble from 
MD of holo and 
apo crystal 
structures 
Docked 
ligand/decoy set 
to conformers in 
Glide 
Found that MD could 
be used to move a 
conformation into a 
predictive range for 
docking 
No correlation 
between MD run 
and AUC 
Identified a correlation 
between the average 
predictive power 
and the average 
flexibility of the 
binding site, such 
that highly flexible 
sites had less utility 
for docking 
A broadly-
applicable 
protocol for 
the application 
of multiple 
receptor 
structures for 
use in docking 
is still a distant 
goal  
No single feature 
can be used to 
pick out 
conformations 
May require 
extensive 
knowledge of 
the system 
Nichols et 
al., 2011 
 
1.6 De Novo Approaches through Fragment-Based Drug Design 
Several interesting experimental methods that naturally account for protein flexibility 
have greatly influenced computational SBDD. The burgeoning field of FBDD has 
allowed for the identification of low-molecular weight binders, which allow for the 
identification of difficult binding sites.156 First introduced by the multiple solvent crystal 
structure (MSCS)157 and SAR-by-NMR158 techniques, FBDD can be performed via NMR 
or x-ray crystallography, and provides a different set of hits from HTS experiments. 
Screening proteins with a fragment collection both verifies the druggability of a target 
system and identifies fragments that can be linked and optimized to develop a viable lead 
compound.159 Importantly, hits from FBDD have been experimentally validated and 
identified novel compounds shown to work in the clinic.160,161 
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The MSCS technique was originally introduced as a crystallography tool for the 
characterization of the binding potential of pancreatic elastase. Other groups have also 
used MSCS to probe ligand interactions in thermolysin162,163, subtilisin164-166, RNase 
A167,168, p53 core169, lysozyme170, and H-Ras171. During crystallization, the water and 
organic solvent acted as probes of binding affinity because the organic solvent, which 
was chosen to represent a common functional group, displaces bound waters only at 
locations with favorable affinity for the particular interaction type presented by the 
protein. MSCS can be performed with a variety of probes, thus enabling the results from 
the protein crystallography experiment to be superimposed in order to identify regions of 
consensus binding.  
When Joseph-McCarthy et al. compared their results from studies with the original 
MCSS (non-grid-based) to results from MSCS, they found that for traditional MCSS it 
was important to consider occupancy at a first site in order to accurately predict 
occupancy at a second binding site.172 English et al. compared the use of MSCS, GRID, 
and MCSS through the exploration of the binding surface of thermolysin with acetone, 
acetonitrile, isopropanol, and phenol acting as functional group probes. The authors 
found that in comparison with MSCS, MCSS and GRID overestimated electrostatic 
interactions, retrieved an overabundance of local energy minima, and could not provide 
detailed descriptions of the interactions between the protein and probes.163  
Although both SAR-by-NMR and MSCS allow for a larger amount of protein 
flexibility then current methods for docking do, they are also both material and time-
intensive. Furthermore, as discussed by English et al., MSCS can be quite slow and probe 
choice is limited by the fragility of protein crystals.163 Computational solvent mapping is 
an complementary approach to experimental fragment-binding studies, however most 
computational approaches do not account for either the impact of protein flexibility or 
proper solvation effects, which can lead of poor mapping results. Over the past two years, 
several groups have developed new methodology for including flexibility and solvent 
competition in computational fragment mapping. While the results of any fragment-based 
study can be translated into a consensus pharmacophore model and used in virtual 
screening applications, the primary objective of MSCS and computational solvent 
mapping has been the correct identification of potential binding sites. 
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Locus Pharmaceuticals developed a method based on a grand-canonical (GC) MC 
simulation for pharmacophore development.173-175 Both studies from Clark et al. were 
performed against a static structure. Their later study concentrated on deriving accurate 
ΔGbind, while their earlier study used 10 simulated annealing runs of GC-MC to explore 
the protein surface of thermolysin with 2 probes and of T4 lysozyme with 14 probes. 
Based on the simulated annealing runs, GB/SA was used to predict binding affinities and 
Clark et al. found that their results retrieved some of the hot spots observed in published 
MSCS data. Moore discussed the use of torsion-space dynamics to generate protein 
flexibility in combination and general outcomes from the use of a 500-member fragment 
library to search target surfaces with GC-MC, however no specific details were given. 
Vadja and co-workers developed a fast algorithm for searching protein surfaces with 
small organic probes that was based on a fast Fourier Transform correlation approach 
(FTMAP).176 In a manner akin to MPS, billions of solvent probes are minimized to the 
protein surface and then clustered based on a simple greedy algorithm. The probe clusters 
demonstrate the position and orientation of proposed hot spots along the target, where the 
largest cluster is defined as the maximal hot spot location; the second largest is the 
second most-important site, and etc. Although FTMAP is another method for 
computational solvent mapping that does not inherently include protein flexibility, 
receptor dynamics could be modeled through serial searches over multiple 
conformations.  
A novel method for probe mapping incorporated solvent competition and protein 
flexibility through MD.177 Based on MSCS, the authors used isopropyl alcohol (IPA) and 
water together to perform a single MD simulation over 16 nanoseconds (ns). The use of 
binary solvent MD inherently accounted for solvation effects and protein flexibility. This 
method was applied to three proteins with experimental MSCS results and five 
pharmaceutically relevant receptors that have not been studied by MSCS; simulation 
probe occupancy was used to differentiate binding sites and predict ΔGbind. This method 
was much more computationally demanding than other computational solvent-mapping 
techniques like FTMAP,176 but may be more competent at distinguishing between 
druggable and nondruggable sites because of the use of flexibility data. Yang and Wang 
used this same solvent-mapping technique to study hot spot mapping against thermolysin 
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together with a double-decoupling method which provided a more rigorously calculation 
of ΔGbind at potential hot spots.178 It is important to note that the analysis of probe 
occupancy to locate binding sites necessarily assumes that Boltzmann sampling occurred 
during simulation, therefore careful selection of the trajectory length required for 
convergence is exceedingly important but frequently neglected in method development.   
Guvench and MacKerell published a similar method, Site Identification by Ligand 
Competitive Saturation (SILCS), where small molecule probes were used to examine the 
binding surface.179 Their technique used all-atom MD simulations of protein in a box of 
propane, benzene, and water as the explicit solvent probes. Ten independent simulations 
over five nanoseconds were generated for analysis and the mapping results were 
represented on a 1Å x 1Å x 1Å grid of volume occupancy. SILCS was capable of 
reproducing known binding interactions for the test case, BCL-6 oncoprotein, and a 
follow-up study further validated the approach on seven proteins from five different 
protein families.180 In their follow up study, MacKerell and co-workers extended the 
simulation time to 10 runs of 20 ns each and scored their occupancy results based on a 
normalized calculation of the observed:expected occupancy, which they termed grid free 
energy (GFE). When compared to the positions of known ligands, their GFE was able to 
select for the crystallographic pose of the bound ligand in several protein families. 
However, in the only available figure of an entire protein surface, SILCS is clearly shown 
to preferentially map many irrelevant minima before identifying the binding site. 
We have developed a computational method that achieves hot-spot-mapping results 
that are similar to available experimental data; Mixed-solvent Molecular Dynamics 
(MixMD). Our multiple protein structure (MPS) method101 for pharmacophore 
development demonstrated success in mapping protein systems for drug design102,103 and 
MixMD complements MPS while simultaneously allowing protein flexibility and probe 
competition with water. MixMD was inspired by the MSCS technique, but incorporates 
more explicit conformational sampling. Since MSCS results identified specific electron 
density that can be attributed to the placement of organic solvent along the protein 
surface, we specifically compare grids of solvent occupancy from simulation to that of 
experimental electron density. Using many, short MD simulations of protein in 50% 
weight/weight (w/w) mixtures of acetonitrile and water, we successful validated MixMD 
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based on the available MSCS structures.181 Similar results were obtained with isopropanol 
(in preparation). 
 
1.7 Limitations of Structure-Based Drug Design 
Most published methods for flexible protein-ligand docking are based on limited sets 
for benchmarking results. The use of a large test set for methods development is crucial 
for demonstrating performance across a range of different targets. Furthermore, docking 
to a flexible protein is more resource and time-intensive than docking to a rigid receptor 
and in many cases ensemble docking is unrealistic for screening huge compound 
libraries. Through the careful development of methods for docking and scoring, the 
computational requirements for accurate simulation may be sufficiently lessened to allow 
for more widespread implementation of flexibility. 
The use of multiple conformations for docking is limited in that several protein 
conformations may decrease the selectivity of lead compounds by increasing the false 
positive rate. Using combinations of features from different conformations may also lead 
to the creation of a ligand with high affinity for an average receptor structure that is not 
experimentally accessible, a so-called “paradoxical inhibitor”. As a result, there is the 
potential for introduction of bias through user intervention in many of these methods for 
flexible docking.  
Due to the rugged landscape of most proteins, not every conformation that is included 
in a low-energy ensemble will adequately represent its true binding potential. This has led 
many recent studies to dedicate their focus to identifying the optimal method for selection 
of only the relevant protein conformations. For this process of conformer selection and 
weighting to succeed, it is crucial that the internal energy of the individual protein 
conformations be included in the scoring process (though this is more difficult to 
properly calculate). Furthermore, it is necessary that the scoring functions used in fully 
flexible procedures be as accurate as possible in order to determine the most physically-
realistic results.  
Experimental FBDD approaches like SAR-by-NMR and MSCS are time-consuming, 
costly, and dependent upon the receptor size and its potential for crystallization. On the 
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other hand, computational FBDD approaches can be just as time-consuming and are 
heavily dependent on proper parameterization and analysis. The trend towards estimating 
binding affinity from computational solvent grids has shown only partial success when 
compared with experimental affinities. Computational FBDD shows great promise as a 
tool for including flexibility and probe-water competition explicitly in a “docking” 
experiment; however, implementation of these methods requires careful consideration of 
the underlying chemistry to ensure reliable results.  
1.8 HIV-1 Protease as a Computational Model 
Since infection with Human Immunodeficiency Virus/Acquired Immunodeficiency 
Syndrome (HIV/AIDS) emerged as a global health threat in the early 1980s182, it has 
become one of the most devastating diseases worldwide.183 The most recent estimates 
(2009) from WHO/UNAIDS reported that 33.3 million people were living with 
HIV/AIDS, 2.6 million were newly infected, and 1.8 million had died due to AIDS.184 
Infection with HIV/AIDS results in immune system failure, eventually resulting in death 
caused by a secondary illness. Although there is no cure, HIV/AIDS is usually treated by 
a combination of highly active antiretroviral therapies (HAART). These drugs target 
various stages of the viral life cycle, including viral enzymes like HIV integrase, 
protease, and reverse transcriptase. While there are a number of therapeutics for people 
living with HIV, many of these therapies are becoming less effective because of drug-
resistant viral mutations. 
HIVp is widely recognized as an important pharmaceutical target for the treatment of 
HIV, the lentivirus that causes AIDS. HIVp is critical to the continued viral life-cycle; it 
cleaves the precursor proteins gag and gag-pol, yielding mature HIV proteins including 
integrase, reverse transcriptase, protease, and the viral matrix, capsid, and 
nucleoproteins.185,186 If HIVp is inactivated, the virus cannot undergo maturation and does 
not become infectious. Despite the existence of ten protease inhibitors (PIs) in clinical 
use187, there is little variety in their mechanism of action. Typical PIs are 
pseudosymmetric and compete with the substrate for binding at the base of the active site. 
Unfortunately, even the most recent PIs suffer from taxing side-effects and poor 
pharmacokinetic properties.188,189 In addition, HIVp is highly mutagenic, particularly in 
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the region surrounding the active site, resulting in the rapid development of drug 
resistance.190-192 Consequently, finding new PIs that can bypass or treat multi-drug 
resistance (MDR) is essential. 
 
1.5.1 HIVp structure 
HIVp is an attractive target for SBDD due to the wealth of structural information 
available from x-ray crystallography, NMR, and MD. HIVp is a C2 symmetric 
homodimer aspartyl protease with two catalytic aspartic acids, residues 25/25’, at the 
base of the binding site. The active site is loosely covered by two glycine-rich α-hairpins, 
or “flaps” (Figure 1-4).193-195 The conformational behavior of the flap region of HIVp has 
been extensively studied in the last few years, as reviewed by Hornak and Simmerling.196 
These flaps are highly mobile and can occupy a range of conformations. NMR and x-ray 
crystallography studies of HIVp demonstrate that the protease can occupy three different 
conformational states: open, semi-open, and closed.197-199 In the apo form, the 
thermodynamically-favored state is thought to be the semi-open conformation, in which 
the flaps are loosely positioned over the active site cavity restricting ligand entry.200-202 
Upon binding to a ligand, the flaps close down over the active site, shifting their position 
by 5-7 Å.203 Differences in flap mobility are a potential contribution to the mechanism of 
MDR for certain HIVp mutants.204  
 
Figure 1-4: The typical semi-open flap conformation for HIVp with each distinct region of the protein 
shown in a different color. The catalytic aspartic acids (Asp25/25’) are shown in stick form. The flaps are 
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shown in dark blue, residues 43-58; the flap tips in yellow, residues 49-52; the fulcrum in orange, residues 
11-22; the cantilever in lime green, residues 59-72; the active site in cyan, residues 23-30; the dimer 
interface in blue, residues 1-5 and 95-99; the elbow in hot pink, residues 35-42; the helix in light blue, 
residues 86-90; the 80s loop or wall turn in red, residues 79-84; and the nose in violet, residues 6-10. 
 
1.5.2 HIVp inhibition 
The flexibility of the flaps and their connection to protease conformation and activity 
has been examined at length.196 A coarse-grained (CG) MD study by Trylska et al. found 
that the substrate waits in proximity to the binding site for the flaps to open long enough 
so that the substrate can enter the active site.205 Another CG dynamics simulation 
demonstrated that when the flaps are semi-open or almost closed the small cyclic urea 
inhibitor XK263 can enter the active site from the side.206 However, the same study also 
showed that a peptide substrate must sample the surface of the protein until it encounters 
an opening event. It is generally held that most ligands, particularly the peptide substrate, 
can only access the active site through the open conformation.205-207 Therefore, it is 
possible that a new class of PIs could be developed to treat HIV through the restriction of 
flap mobility. Most of the mutations seen in HIVp occur around the binding site,208 so by 
targeting flexibility of the protease with an allosteric inhibitor, existing drug resistance 
could be avoided. There are three different allosteric sites with the potential to control 
HIVp allosterically: the elbow, the eye103, and the dimer interface. By controlling motion 
at these sites, the position of the protease flaps may be altered, thus affecting access of 
the peptide substrate to the binding site. Development of a new strategy to treat HIV 
infection by targeting HIVp would lead to the first new class of inhibitors since the 
introduction of dimerization inhibitors more than twenty years ago.209,210  
1.9 Summary 
The major areas addressed in this thesis include protein flexibility, allosteric control, 
and hot-spot prediction.  
Chapters 2 and 3 focus on computational probe mapping through MD simulations of 
proteins in binary solvent. Probe mapping is a commonly used computational technique 
for identifying potential binding pockets along a protein surface, but it typically relies on 
gas phase calculations against a rigid protein. Chapter 2 discusses the development and 
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validation of a new method, mixed-solvent molecular dynamics (MixMD), that 
simultaneously allows for the probe’s competition with water and protein flexibility. 
Chapter 3 highlights the generalization of the MixMD approach to a broad range of 
pharmaceutically relevant protein targets. Additionally, the correct implementation of 
solvent parameters as well as the impact of simulation time on convergence is examined.  
Chapters 4 and 5 consider the use of explicit-solvent molecular dynamics (MD) to 
examine the potential for allosteric regulation between small molecules and HIVp. 
Chapter 4 presents an in-depth study of the interactions between HIVp and symmetric 
pyrrolidine inhibitors that complement the semi-open conformation of HIVp. This work 
dove-tails with previous studies in the Carlson Lab suggesting the eye site as a possible 
alternative to traditional competitive inhibitors. Chapter 5 discusses my initial studies in 
the Carlson Lab into the impact of small molecules at the elbow region. The work 
detailed in Appendix A is an extension of these HIVp-elbow studies, where we employed 
positional restraints and small beads to examine the structural properties of a potential 
compound that could target HIVp as an allosteric regulator. While the studies presented 
in Chapters 2-5 represent work that has been published or is in preparation for 
publication, the study in Appendix A was not published.  
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Chapter 2  
Full Protein Flexibility is Essential for Proper Hot-Spot Mapping 
2.1  Introduction 
We have developed a new protocol for using Mixed Solvent MD (MixMD) to 
identify important hot spots. Our multiple protein structure (MPS) method211-213 for 
creating binding-site pharmacophore models based on conformational ensembles has 
demonstrated success in mapping protein systems for drug design.102,103 MixMD expands 
the MPS concept while combining ideas from MSCS to simultaneously allow protein 
flexibility and competition between probes and water. 
Several similar efforts have incorporated MSCS concepts into a computational 
method, but each has notable limitations. FTMap176 is modeled after MSCS, but while it 
can be used with ensembles like MPS151, neither ligand nor on-the-fly protein flexibility 
is used during probe mapping. A recent study from Seco et al. utilized MD with mixed 
water and isopropanol to detect binding sites and predict potential druggability.177 
However, the method was unable to reproduce many known binding sites. SILCS is a 
mapping method that incorporates a ternary solvent system (benzene, isopropanol, and 
water) with MD to map sites.179,180 Therefore, these methods are in their infancy and 
require significant development to provide a robust tool for SBDD. Here, we present 
initial findings based on our MixMD protocol that should have significant impact on 
solvent mapping approaches.  
Hen egg-white lysozyme (HEWL) is a canonical model system that allows for 
appropriate testing and validation of MixMD to identify hot spots. A MSCS of HEWL 
was produced using acetonitrile (CCN) as the organic solvent.170 The high quality 
electron density available for this structure allows for an accurate assessment of MixMD 
data. Below, we demonstrate how occupancy grids for both the probe and water can be 
directly compared to electron density. 
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2.2 Methods 
The starting structure of HEWL in CCN and water (2LYO)170 was obtained from the 
PDB214. We performed all-atom MD simulations of the HEWL protein in the presence of 
multiple solvents using standard procedures for sander in AMBER1010 at 300K. Pre-
equilibrated solvent boxes with an even distribution of 50% weight/weight (w/w) CCN 
and water were used. Simulation set-up was completed in tLeAP using the ff99SB force 
field7, TIP3P water215, neutralizing ions, a 10 Å vdw cutoff, and CCN parameters from 
Grabuleda et al216. A time step of 2 fs was implemented, temperature was controlled 
through an Anderson thermostat217,  and SHAKE was applied. Three different protocols 
for protein flexibility were evaluated for proper sampling and convergence: all-atom 
restrained, backbone restrained, and fully flexible HEWL. Five independent simulations 
with 10 ns of production time each were performed for every system, initiated from the 
same solvent configuration. Though it might enhance sampling to have alternate starting 
locations for solvent in each simulation, it would make it more difficult for us to properly 
evaluate convergence in the simulations. 
The stability of the protein core was verified on the basis of low backbone RMSD 
over the course of the trajectory, as measured with ptraj. The presence of mixed solvent 
did not destabilize the unrestrained protein on the timescale examined. 
Five independent trajectories of 10 ns each were performed, but for the analysis we 
combined the last 2 ns of each simulation to provide the most “equilibrated” 10 ns of the 
available 50 ns of simulation time. To calculate the solvent grids, the central C2 atom of 
acetonitrile and the oxygen atoms for water were binned into 0.5 Å × 0.5 Å × 0.5 Å 
volume elements, which spanned the entire box. The electron density from the initial 
crystal structure and the grids from MD simulation were compared in Chimera218 to 
examine the ability of MixMD to recover known hydration sites and binding sites of 
CCN.  
The CCP4i suite219 was used to produce electron density grids for the solvent probe 
density in the original crystallographic study. The ptraj function in AMBERTOOLS1.2 
was used to generate grids of solvent density from simulation data. Prior to grid output, 
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each trajectory was centered, imaged, and aligned to the protein core backbone from the 
2LYO crystal structure.  
Convergence in the simulations was examined with several measures. The first test 
compared the grids between the five independent simulations (the last 2 ns from each that 
were used to make the 10 ns of sampling noted above were calculated separately). 
Difference grids were calculated to determine differences in the density data. The second 
test compared the position of maximal occupancies for each of the five separate 
simulations. The 99% maximum occupancy calculation yields the grid points with the 
highest occupied solvent density. 
Third, the influence of the protein should be minimal at the box edges. Therefore, the 
ratio of probe to water on the distal points of the occupancy grids should simply approach 
the ratio of the total number of probes to water in the simulation. Occupancy grids within 
5 Å of each box boundary were examined. The ratio of probe occupancy to water 
occupancy was compared to the ratio of probes and water in the initial system set up. 
Occupancy within 5 Å from the box boundary for each plane was used to calculate this 
ratio. Correspondence between the two different ratios implies adequate sampling has 
occurred (values near 1.0). The calculation of this ratio was performed through a python 
script in Chimera. 
 
2.3 Results and Discussion  
The positions of the solvent from the sander trajectories were converted into 
occupancy grids using ptraj. In this way, we were able to directly compare our solvent 
“density” results to electron density data obtained in the crystallography study. This 
allowed for an equivalent comparison of solvent positions during simulation with solvent 
occupancy from crystal studies, which is a more even assessment than simply using the 
solvent coordinates given. (In the figures below, crystallographic coordinates for CCN 
and water are often used in place of electron density to avoid the confusion of overlaying 
many grids.) Technically, the equivalent data to crystallographic density would be an 
occupancy grid based on all atoms of the simulation (protein, water, CCN, and counter 
ions), but we have made the simplification of examining only solvent-occupancy grids.  
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Our initial simulation used mobile solvent and a fixed protein; we aimed to establish a 
minimum sampling time required for the solvent to reproduce the MSCS results. We 
assumed that the mapping would identify the position for CCN and that longer sampling 
times would be required as more flexibility was allowed for the protein. Instead, we were 
surprised to find that our simulation of the rigid protein converged to multiple, trivial 
minima (Figure 2-1). Though the CCN hot spot in the crystal structure was mapped with 
weak occupancy, it was equal to and less than many incorrect sites. When we added side-
chain flexibility (backbone still fixed), a variety of incorrect sites were again located, but 
the correct location was not. Only when full protein flexibility was allowed was the 
correct location for the CCN hot spot found and the trivial minima eliminated.  
 
Figure 2-1: Results from unrestrained vs. restrained protein simulations using CCN and water to solvate 
HEWL (white). The single hotspot identified by MSCS is shown in stick form; CCN (cyan). The probe 
density from the fully restrained simulation is shown in orange, from backbone-restrained in green, and 
from fully flexible in blue. Many incorrect local minima are seen in green and orange, but only the correct 
position dominates the simulation of the fully flexible protein in blue.  
It appears that the numerous local minima obtained when performing gas-phase 
minimizations of probe molecules are not an artifact of the vacuum; they are an artifact of 
using a rigid protein conformation. A rugged landscape is observed, even in the presence 
of mobile solvent and side chains. The abundant local minima cannot be distinguished 
from the binding site, and probe mapping cannot successfully differentiate between 
irrelevant and druggable hot spots. With full receptor flexibility included, MixMD 
appropriately reproduces the one hot-spot binding site seen in the crystallographic data 
 45 
 
for CCN. The agreement between simulation data and experimental electron density 
validates MixMD as an accurate mapping tool (Figure 2-2). 
 
Figure 2-2: MixMD data for the fully flexible simulation agrees well with densities from MSCS experiments 
using CCN and water. All snapshots were superimposed on the crystal structure of HEWL (white surface). 
MixMD density for water is shown as a red mesh, and crystallographic waters are colored black for B-
factors below 33 Å and yellow above 33 Å. The MSCS coordinates for CCN are shown in stick form (cyan 
with its electron density as a mesh, 2FO-FC shown at 1.5σ); the highest occupancy for CCN in the fully 
flexible simulation matches perfectly and is shown in solid blue surface. Unsatisfied electron density in the 
crystal structure (positive FO-FC shown at 3σ) is shown in solid purple. (A) Water maps within the protein 
highlight interior waters conserved in the crystal structure and reproduced in our simulation. The large 
astrices (*) denote two highly occupied regions of the interior water map that correspond to unfulfilled 
density in the crystal structure. (B) Maps of the protein surface show good correspondence between 
crystallographic and MixMD densities for both CCN and well resolved waters. For the 16 crystallographic 
waters with B-factors below 33 Å (black spheres) five occur at symmetry-packing interfaces. MixMD 
misses four of the five, which is expected because the contacts are not present in our simulation. The other 
11 best-resolved waters are well reproduced. 
In addition to the CCN hot spot, MixMD reproduced the locations of low-B-factor 
water (<33 Å). The only locations that were not reproduced were on surfaces of the 
protein that were involved in crystallographic contacts (Figure 2-2B). A few locations 
were seen where significant water occupancy in the interior of the protein did not 
correlate with water coordinates in the crystal structure, but those locations were in 
excellent agreement with unfulfilled density in the crystal structure (Figure 2-2A). The 
location of positive density on the Fo-Fc map may in fact correspond to water positions. 
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While not all unfulfilled density will correspond to solvent molecules, the locations 
identified by MixMD water maps may indicate positions where water should have been 
placed. 
2.3.1.  Convergence of Sampling 
Though the 10-ns sampling time used in the simulations is relatively short by current 
standards, it is important to stress that long trajectories are inappropriate in mixed 
solvent. Modest timescales are needed: long enough to allow solvent equilibration and 
convergence, but short enough to avoid possible unfolding of the protein. Furthermore, 
an accurate MD technique built on short timescales makes this method more accessible 
for practical application in a pharmaceutical setting. 
We calculated the maximal occupancy location of each probe type during each 
individual simulation using the ptraj grid utility. These positions for CCN over the last 2 
ns of production were compared between independent simulations of the same initial 
system (Figure 2-3). Excellent convergence is seen across the five independent MixMD 
of the fully flexible HEWL. However, the individual simulations of the rigid and 
backbone-fixed simulations did not agree on a common location for the CCN hot spot, 
reflecting a propensity for solvent molecules to become trapped within local minima 
along the protein surface. For the fully flexible simulation, these points were all within <1 
Å, which is within the limits of accuracy when using a 0.5 Å grid. Not only did the 
locations agree with one another, they were in excellent agreement with the position for 
CCN in the crystal structure. In contrast, there was no agreement between the five 
independent MixMD simulations of the rigid and backbone-fixed HEWL. Those 
simulations also failed to identify the correct location for the CCN hot spot, except for 
one trajectory of the rigid HEWL. 
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Figure 2-3: The maximal occupancy positions over the last 2 ns for each independent simulation of HEWL 
in pre-equilibrated 50% w/w CCN and water. Only the fully flexible system shows convergence of the five 
simulations in agreement with experiment. Individual runs are indicated by color (red, orange, yellow, 
green, and blue). 
To further compare sampling, we calculated the ratio of the number of solvent probes to water molecules at 
the edges of the box. Far from the protein, there should be no bias between the solvents, and the ratio of 
their occupancies should approach Np/Nw (ratio of the number of CCN probes to the number of water in the 
simulation).220 All systems demonstrated good convergence according to this metric with the fully flexible 
system being the least biased (Table 2-1,  
 
 
Table 2-2). The fact that CCN and water exchange freely at the box edge indicates 
that the mixed solvent system inherently samples evenly, but the pronounced differences 
at the protein surface indicate that solvent molecules become trapped and poorly sample 
the rugged potential surface of a rigid or semi-rigid protein.   
Table 2-1: The extent of convergence for HEWL in MixMD, as determined by the ratio of co-solvent to 
water molecules at the box edges. Values of Obs/Exp near 1.0 indicate complete and unbiased sampling at 
the edges of the box. 
 Pre-equil 50% Fully  
Flexible 
Pre-equil 50% 
Backbone Restrained 
Pre-equil 50% All Atoms 
Fixed  
(Np/Nw)Obs 0.4501 0.4664 0.4709 
(Np/Nw)Exp 0.4490 0.4490 0.4490 
Obs/Exp 1.0024 1.0388 1.0488 
 
 
 
 
S2 
 
 
CCN parameters3 
Atom Type NY CY CT HC 
q (e) -0.533 0.481 -0.479 0.177 
 
 
 
Convergence of Simulations of All-Atom Rigid, Backbone Fixed, and Fully Flexible HEWL in Pre-equilibrated Solvent 
 
Figure S1: The maximal occupancy positions over the last 2 ns for each independent simulation of HEWL in pre-equilibrated 50% w/w 
CCN and water. Only the fully flexible system shows convergence of the five simulations in agreement with experiment. Individual runs 
are indicated by color (red, orange, yellow, green, and blue). 
       
 
 
 
Table S1: The extent of convergence for HEWL in MixMD, as determined by the ratio of co-solvent to water molecules at the box edges. 
Values of Obs/Exp near 1.0 indicate complete and unbiased sampling at the edges of the box. 
 Pre-equil 50% 
Fully  
Flexible 
Pre-equil 50% 
Backbone 
Restrained 
Pre-equil 50% 
All Atoms 
Fixed  
(Np/Nw)Obs 0.4501 0.4664 0.4709 
(Np/Nw)Exp 0.4490 0.4490 0.4490 
Obs/Exp 1.0024 1.0388 1.0488 
 
 
 
  
Fully Flexible Backbone Restrained All-Atom Fixed 
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Table 2-2: The extent of convergence for fully flexible HEWL in MixMD, as determined by the ratio of CCN 
to water at the box edges. Simulations of 90% w/w CCN were problematic, and the behavior at the edges of 
the box show that they do not demonstrate even, unbiased sampling (the Obs/Exp value is much larger than 
1.0). 
 Pre-equil 
50% w/w 
Layered 
50% w/w 
Layered 
10% w/w  
Layered 
90% w/w  
(Np/Nw)Obs 0.4501 0.4619 0.0477 4.7453 
(Np/Nw)Exp 0.4490 0.4314* 0.0489 3.6563 
Obs/Exp 1.0024 1.0707 0.9755 1.2978 
* The layered 50% box contained a few more water molecules than the pre-mixed box, giving it a slightly different 
expected (Np/Nw). 
2.3.2.  Initial preparation of the mixed solvent environment 
The results above were obtained with a pre-equilibrated 50% w/w solution, but we 
have also examined other choices for the mixed solvent environment. Two protocols for 
initiating the mixed solvent box were compared. The first used the pre-equilibrated 50% 
w/w mixed solution, providing an even distribution of both solvents (data shown above). 
The second method aimed to reproduce the MSCS experiment where the CCN has to 
compete water off the surface of the protein. The waters were placed in a shell around the 
protein, and the CCN were placed outside the water shell, resulting in a layered solvent 
environment.  
 
Figure 2-4: Combined results from the last 2 ns of all 5 simulations (10 ns of sampling) with flexible HEWL 
(white surface), comparing the layered solvent to the pre-equilibrated protocol. The probe density is shown 
in blue mesh for 50% w/w pre-equilibrated solvent and in orange mesh for 50% w/w layered water and 
CCN. The highest sampled densities overlap exactly and agree well with the position of CCN in the 2LYO 
crystal structure. 
Densities of CCN were in good agreement between the two solvent protocols (Figure 
2-4). Maximal occupancy positions were used to compare coordinates of the 
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experimental probes to simulation probes. For simulations of fully flexible HEWL, we 
found that the layered solvent produced a maximally occupied location 0.8 Å from the 
crystallographic C2 atom of CCN. The pre-equilibrated, evenly mixed solvent produced a 
maximally occupied location 0.9 Å from the crystallographic C2 atom of CCN. These 
maximally occupied locations were 0.5 Å away from each other. Again, this is within the 
limits of error of our grids for calculating the occupancy maps. It appears that either 
protocol may be appropriate for 50% w/w CCN and water (Error! Reference source not 
ound.), but the layered solvent showed a slight disagreement in the convergence of the 
five independent simulations (Figure 2-5). 
 
 
Figure 2-5: The positions of maximal occupancy on the CCN grid were calculated over the last 2 ns for 
each independent simulation around a fully flexible HEWL (white). A) Results for the individual 
simulations based on pre-equilibrated solvent are shown. All five positions are in excellent agreement with 
one another and the CCN molecule in the 2LYO structure. The second (orange) and fourth (green) run 
results lie beneath the first (red) and fifth (blue) run results. B) Results for the individual simulations based 
on layered solvent are shown, with the orientation skewed slightly from A to show the green site (run 3) 
that does not agree. Four of the five positions are in agreement with one another and the crystallographic 
CCN. The first run result (red) lies beneath the fifth run result (blue). 
We have also examined 90% and 10% w/w mixed solutions of water and CCN to 
determine whether maps are more accurate when more or fewer probes are present. Both 
90% and 10% mixtures identified the correct hot spot for CCN (Figure 2-6). However, 
we found that the 50% mixtures gave better water maps and more complete sampling 
than either 90% or 10% mixtures of CCN and water (Figure 2-7). 
S3 
 
Convergence of Simulations of Fully Flexible HEWL in Pre-equilibrated and Layered Solvent Boxes 
 
Figure S2: Combined results from the last 2 ns of all 5 simulations (10 ns of sampling) with flexible HEWL (white surface), comparing 
the layered solvent to the pre-equilibrated protocol. The probe density is shown in blue mesh for 50% w/w pre-equilibrated solvent and in 
orange mesh for 50% w/w layered water and CCN. The highest sampled densities overlap exactly and agree well with the position of CCN 
in the 2LYO crystal structure. 
 
 
Figure S3: The positions of maximal occupancy on the CCN grid were calculated over the last 2 ns for each independent simulation 
around a fully flexible HEWL (white). A) Results for the individual simulations based on pre-equilibrated solvent are shown. All five 
positions are in excellent agreement with one another and the CCN molecule in the 2LYO structure. The second (orange) and fourth 
(green) run results lie beneath the first (red) and fifth (blue) run results. B) Results for the individual simulations based on layered solvent 
are shown, with the orientation skewed slightly from A to show the green site (run 3) that does not agree. Four of the five positions are in 
agreement with one another and the crystallographic CCN. The first run result (red) lies beneath the fifth run result (blue). 
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Figure 2-6: Results from the three different solvation protocols with fully flexible HEWL and CCN as the 
organic probe. The probe density calculated by combining the last 2 ns of the five independent simulations 
(to give 10 ns of sampling) is shown as a purple mesh for 90% w/w CCN, as a blue mesh for 50%, and as a 
green mesh for 10%. Results from all three simulations are nearly identical and reproduce the 
crystallographic position of CCN. 
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Figure 2-7: The water density calculated by combining the last 2 ns of the five independent simulations 
(giving 10 ns of sampling) is shown.  The water density is shown as a green mesh for 10% w/w CCN (A), as 
a blue mesh for 50% (B), and as a purple mesh for 90% (C). The separate solvent densities are overlaid in 
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(D). Crystallographic waters are colored black for B-factors below 33 Å and yellow above 33 Å. Although 
the 10% and 90% environments reproduce the CCN position, they do not give appropriate mapping for the 
water.  In A, too many equivalent positions for water are seen without identifying the water with higher B-
factor (yellow).  In C, there are too few water locations. 
2.4 Conclusion 
Our results demonstrate the need to include protein flexibility to achieve valid hot-
spot mapping. MixMD simulations have been successfully performed to determine the 
correct mapping procedure for locating truly relevant binding minima. MixMD was 
capable of locating hot spots for the CCN solvent probe, and it identified crystallographic 
waters with the lowest B-factors, crystal contact waters, and locations where water could 
have been modeled into the structure (unsatisfied density in the FO-FC map). The 
information contained within individual MixMD trajectories can be combined into a 
consensus model retaining only the consistently important mapped sites. We have shown 
that only through the incorporation of protein flexibility and appropriate solvent 
competition can viable mapping results be obtained.  
 
This work was published as: Lexa KW and Carlson HA. Full Protein Flexibility is 
Essential for Proper Hot Spot Mapping. J Am Chem Soc 2011, 133, 200-202.  
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Chapter 3  
How to Compare Computational Probe Mapping to Crystal Structures 
3.1 Introduction 
The development of FBDD as a compliment to traditional SBDD has allowed 
discovery efforts to probe binding potential across a broad range of protein structures, 
including many traditionally difficult cases. FBDD was first introduced as a viable tool 
for drug discovery in 1996 with the SAR-by-NMR and multiple solvent crystal structure 
(MSCS) methods.157,158,221 In the first SAR-by-NMR study of protein-ligand binding, 
small organic molecules with low molecular weight were screened for binding affinity to 
FKBP and their bound positions were determined from 15N-HSQC spectra.158 The authors 
identified low-affinity binding sites along the protein surface, optimized the resultant hits, 
and then linked the fragments together, thereby achieving ligands with nanomolar affinity 
for FKBP. In the original MSCS study, cross-linked crystals of elastase were soaked in a 
solution of CCN, allowing CCN to compete off water and form favorable interactions 
along the protein surface. Then, the crystals were washed to remove unbound CCN, 
enabling the crystallographers to identify optimal binding sites for amphiphilic nitrogen-
containing fragments. The authors concluded that the MSCS results from several organic 
probe types could be superimposed and translated into a template, or pharmacophore, for 
drug design. Both x-ray crystallography and NMR techniques allow for the identification 
of hot spots, defined as sites where a small number of protein residues confer most of the 
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free energy of binding.222,223 These hot spots signify regions where important protein-
ligand interactions may be formed and thus represent a tool for the design of novel 
therapeutics. 
FBDD has been effectively implemented in the development of clinical 
candidates.224,225 However, many combinations of linked fragments may be required 
before identification of a viable lead compound. Computational techniques can be used to 
complement the existing experimental methods for FBDD by offering a less costly 
approach to the examination of potential binding interactions in the target system. Several 
groups have recently developed computational techniques that incorporate concepts from 
MSCS into MD simulations. The first of these computational approaches to probe 
mapping used a single 16 ns MD simulation of protein solvated by a box of 20% 
volume/volume (v/v) IPA and water to identify hot spots based on grid occupancies and 
calculated binding free energies.177 The second MD-based approach, SILCS, relied upon 
a ternary solvent box of 1M benzene, 1M propane, and water to calculate probe 
occupancies and map the potential energy surface.179,180 However, each of these methods 
has been limited by the identification of irrelevant local minima with equal weight as the 
true binding site(s). With this problem, extrapolation to cases where the answer is 
unknown becomes very difficult. An improved sampling protocol that reduces spurious 
minima is essential for robust application. Spurious local minima are also a common 
problem among the traditional computational probe-mapping techniques like GRID91 and 
MCSS92.  
The FTMAP algorithm176 deserves mention because it was also based on 
experimental methods for fragment mapping. It applies a fast, Fourier-Transform 
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approach to correlate the docking of billions of probe conformations to a rigid protein. 
While it does not dynamically sample protein flexibility like the MD-based methods, it 
does not identify as many spurious minima as other probe-mapping methods.  
In our development of MixMD, we focused on providing a computational tool 
complementary to the MSCS approach that would preferentially locate the most relevant 
hot spots along a protein surface.181 MSCS studies can be difficult to perform with fragile 
crystals or at a high concentration of organic solvent, and results can be influenced by the 
crystallization conditions. Computational studies avoid these limitations and enable the 
detailed study of protein-probe interactions. Our original MixMD study was the first 
computational technique to definitively show the need to include full protein flexibility to 
reduce extraneous minima and correctly map a protein surface. Our initial studies of 
HEWL in CCN and water demonstrated the utility of MixMD for hot-spot mapping, and 
we would like to incorporate additional functional groups, to permit consensus 
pharmacophore modeling of putative binding sites. We were particularly focused on the 
impact of length and number of simulations on solvent behavior and protein structure. To 
determine the appropriate MixMD approach that would be applicable to systems where 
the binding site(s) are unknown, we have performed MixMD for a range of protein cases 
with the most common MSCS probes: IPA and CCN.  
Hot-spot data are available for IPA and CCN with the following proteins: elastase, 
HEWL, p53 core, RNase A, subtillisin, and thermolysin. These probes were originally 
selected for MSCS based on their miscibility with water, their interaction type, and the 
ease of distinguishing their crystallographic density from that of water.221,226 Due to the 
subjective nature of assigning experimental density to specific atoms, the most valid 
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comparison between simulation and MSCS is between occupancy grids and experimental 
density data. As a result, we focused primarily on cases with electron density data 
available: elastase+IPA, HEWL+CCN, HEWL+IPA, p53 core+IPA, RNase A+IPA, and 
thermolysin+IPA. Structure factor files were not available for elastase+CCN (coordinates 
obtained from author221), subtillisin+CCN (1SCB166), or thermolysin+CCN (1FJU163) but 
our simulations of these systems showed that our results agreed with the known binding 
sites of these proteins. These proteins vary in size and active-site composition, thus 
providing a variety of interaction types to explore through MixMD to develop the most 
robust protocol with the greatest potential for application to new proteins. 
 
3.2 Methods 
HEWL+CCN was the focus of our previous study.181 So we extended CCN+water to 
new systems and added IPA as a probe. We concentrated on the systems with 
experimental density data available for this study. The starting structures for 
elastase+IPA (2FOF227), HEWL+IPA (1LY0228), p53 core+IPA (2IOM229), RNase A+IPA 
(3EV2167), and thermolysin+IPA (7TLI226) were obtained from the PDB214. 
Crystallographic waters and structural ions were retained to maintain their stabilization of 
the protein conformation, but all probe molecules and crystallographic ions were 
removed. We emphasize that no simulations were initiated with the probe in the 
experimental conformation. Molprobity230 was used to check the side-chain orientations 
of ASN, GLN, and HIS, and these results were confirmed by a visual examination. 
The crystallographic structure of RNase A contained two copies of the protein within 
the asymmetric unit. Chain B was selected for use in our simulations because chain A 
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was missing several residues. Furthermore, chain B contained two IPA molecules located 
in the active site, while chain A contained two IPA molecules that were located along a 
packing interface. 
Parameters for IPA were based on the OPLS-AA parameters for pure alcohols from 
Jorgensen et al.231 This choice was based on an in-depth exploration of available solvent 
parameters, discussed in a forthcoming publication. Parameters for CCN were obtained 
from Kollman and co-authors and implemented as described in our established MixMD 
protocol.181 
The atomic coordinates from the MSCS studies were used for each system. Using the 
AMBER10/AMBERTOOLS 1.2 package10 and FF99SB parameter set7, hydrogens were 
added to the protein by tLeAP and minimized in sander. The protein was solvated in an 
18-Å pre-equilibrated box of 50% w/w probe and TIP3P water215, and then ions were 
added to neutralize the system charge. Simulations used a 2-fs timestep, SHAKE4 to 
restrain bonds to hydrogen, and a 10-Å cutoff for Particle Mesh Ewald232 approximations 
of long-range vdW interactions. The initial velocities of each independent simulation 
were generated from a different random number seed. Temperature was regulated 
through an Anderson thermostat.217 Each system underwent 250 cycles of steepest-
descent minimization followed by 4750 cycles of conjugate-gradient minimization with 
the protein fixed. Then, each system was gradually heated from 10K to 300K over 80 ps 
while the protein was gently restrained by a harmonic force constant of 10 kcal/mol*Å. 
These restraints were gradually removed over 500 ps of equilibration until the protein 
was fully flexible. Five independent 50-ns simulations were performed simultaneously 
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for each MixMD system; for elastase and thermolysin, a total of 10 independent 50-ns 
simulations were generated.  
Since our binary-solvent simulations commenced from the crystal coordinates of the 
MSCS structure, we could use a common frame of reference to accurately compare our 
simulation data with the crystallographic density data when available. The results of our 
MD simulations were analyzed using ptraj, a module within the AMBERTOOLS 
package. The final 5 ns of each individual run were read into ptraj and combined to 
represent the converged system density data. The simulation data was first imaged and fit 
to the crystal conformation by Cα-RMS; then the solvent occupancies of water and probe 
were calculated using the grid command with a 0.5 Å x 0.5 Å x 0.5 Å spacing over the 
entire box. To correlate with experimental data, occupancies were examined for each 
solvent heavy atom, each solvent residue, both solvent types together, and all atoms. The 
occupancy grid for all atoms is the equivalent of the electron density in the crystal 
structure, but it removes the identity of which atoms are populating the grid points. 
Contour levels for probe density were chosen such that the first 5 maximally-occupied 
regions were visible (i.e. the 5 hottest spots) in order to extrapolate from our results to the 
best approach for analysis of systems where the answer is unknown. 
 
3.3 Results and Discussion 
3.3.1. Electron density 
The most accurate comparison between experiment and computation involves a joint 
examination of the MSCS electron density and the occupancy grids from the MixMD 
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simulation. Although the MSCS probes were specifically chosen to aid in identification 
of crystallographic density, placement of probes is necessarily subjective. Electron 
density cannot be unambiguously assigned in many cases, so occupancy grids for solvent 
should not be directly compared to atomic coordinates. It is often unclear whether density 
represents the position of a probe or a water molecule, and the placement of one of these 
versus the other can affect the final density map. 
Electron density maps are typically presented as 2FO-FC and FO-FC maps, where FO 
refers to the observed phasing information and FC refers to the calculated phasing 
information. The 2FO-FC map illustrates true structure features, while the FO-FC map is a 
difference map of areas where FO does not match FC. When examined at a sufficiently 
high level (≥ 2.5σ), noise in the FO-FC map is minimized, and it shows positive peaks that 
indicate structure features which may be missing in the model as well as negative peaks 
that represent features in the model which are in error. The atomic coordinates for all 
probes must be compared to the refined FO-FC map to ensure that each is supported by 
appropriate electron density (Table 3-1).  
Table 3-1: Analysis of the refined cycles in Buster of electron density for each MSCS probe site in the noted 
crystal structure. The real-space correlation coefficient from the EDS is shown in parentheses. 
Protein-Probe System Unsupported Probe 
Density 
Supported Probe 
Density 
Supported at an 
Interface 
HEWL (1YL0)  2836 (0.934) 2837 (0.741) 
p53 core (2IOM)  3001 (0.889)  
RNase A (3EV2) 905A (0.934)*, 917A 
(0.881), 903B (0.485)* 
902B (0.723)  
Elastase (2FOF)  1001 (0.823), 1003 
(0.871) 
1002 (0.898), 1002x 
Thermolysin (7TLI) 2004 (0.838), 2005 
(0.742), 2007 (0.703), 
2008 (0.693)* 
2001 (0.837), 2002 
(0.872) 
2003 (0.494), 2006 
(0.921) 
 *Density does not support a probe site, but is instead a potential water site 
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There are several caveats inherent to this comparison. Crystallographic density may 
include artificial features influenced by experimental conditions and crystal contacts. As 
Allen et al. acknowledged in their MSCS study of elastase+CCN221, several of the CCN 
probes were involved in crystal-packing interactions and were not believed to indicate 
true hot spots for binding. Therefore, probes near crystal-packing interfaces required 
additional scrutiny (Figure 3-1). Depending upon the protein system, it may not be 
possible to reproduce the probe location at an interface because it is not favorable in the 
solution phase simulated in MixMD.  
 
 
 
Figure 3-1: The MSCS of elastase+IPA228 is shown in violet (right) with a neighboring symmetry partner in 
cyan (left). The symmetry-related equivalent IPA in both structures are circled in red. One of the bound 
IPA probes in the symmetry partner is located within 4 Å of the protein in the initial unit cell. When the 
probe site is support by the refined electron density, it is necessary that it receive special consideration 
during evaluation of the simulation data. Probes at the contact interfaces may be irreproducible, but when 
they are observed, the probe may map to either or both of the circled sites on the protein. 
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3.3.2. Identifying probes with appropriate density 
 It must be stressed that crystallographic structures can be subject to phase bias/ 
experimental uncertainty, and accurate comparisons between theory and experiment can 
only be made when the limitations of both are understood. To properly confirm that a 
probe site is supported with appropriate density, the FO-FC map must be regenerated with 
that particular probe excluded from the set of atomic coordinates. This removes the bias 
of the probe on the determination of the density. This procedure was important for 
confirming hot spots in the crystal structure, and it was just as important for our analysis 
of any “spurious” sites observed in the occupancy grids from MixMD. In some cases, 
“spurious” sites actually reflected the position of a valid probe site in the neighboring unit 
cell. Thus, it was important to examine the surrounding symmetry partners present in the 
crystalline environment for probe sites in contact with the central protein. When refined 
density maps were generated, several outcomes were possible. The probe and/or probes 
along the crystalline interface could be well-placed in the positive FO-FC density, the FO-
FC density at the probe site appeared to support placement of a water molecule, the probe 
was placed in negative FO-FC density, or there was not sufficient density to justify 
placement of any molecule (Figure 3-2).  
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Figure 3-2: Refined density maps calculated for several of the MSCS structures. The refined maps were 
based on the coordinate file for the MSCS structure, with probes and close-contact waters/ions removed. 
The positive FO-FC density is contoured in green; the negative FO-FC density is contoured in red at 3.0 σ. 
This illustrates regions where crystallographic probes are justified or not justified, respectively. In A, the 
positive FO-FC density from the MSCS of elastase+IPA (2FOF) clearly agrees with the probe placement, 
where IPA.1001 and IPA.1003 are located in the active site with good agreement between coordinates and 
density (IPA.1002 is located near the crystal interface). The positive FO-FC density in B indicates that the 
site for IPA.905A in RNase A+IPA (3EV2) may best correspond with a water molecule. In C, the FO-FC 
density along the active site of thermolysin+IPA (7TLI) indicates that the site for IPA.2001 is justified 
while the sites for IPA.2005 and IPA.2008 might best support a water molecule as opposed to a probe. In 
D, the FO-FC density in p53 core (2IOM) illustrates that this probe is justified in the crystal structure. 
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CCP4i233 was used to derive crystallographic density for each MSCS probe and to 
rotate maps of the simulation density into the crystal structure orientation. In CCP4i, the 
pdb and structure factor files were used to derive the mtz file, which was then refined 
through one complete round of Buster234 (five cycles). To verify the probe locations in 
MSCS, each probe was removed from the structure individually. The density in these 
figures has been generated through a refinement cycle and is therefore not equivalent to 
the ready-made mtz file that is electronically-available through the Uppsala Electron 
Density Server235. Chimera218, COOT236, and PyMol237 were used for visualization of 
results. Instead of displaying an additional density layer in the figures, presentation was 
simplified by showing the MSCS probes whose positions were confirmed by the FO-FC 
density from Buster234 in cyan and probes without adequate density in gray as ball-and-
stick coordinates.  
 
3.3.3. Appropriate Simulation Length: Adequate Sampling and Convergence 
We were interested in establishing the appropriate simulation length for MixMD to 
allow widespread application of hot-spot mapping, including cases where the active site 
might be unknown. In order to determine the appropriate methodology to be used with a 
protic probe, which should diffuse more slowly than an aprotic probe, we first had to 
define appropriate system behavior. All of the mixed-solvent simulations were stable 
over the ns timescales examined here. Long timescales should reveal unfolding of the 
protein and are less desirable. To assess whether adequate mixing of the two solvents had 
occurred, we examined the number ratio of probe to water (Np/Nw) at the edges of the 
box. In a properly mixed system, Np/Nw at the edges of the box will correspond with 
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Np/Nw of the whole system, since the presence of the protein should not impact the 
distribution of solvent at the box edges. We found that this was indeed the case within 5 
Å of the box edges; therefore, our binary solvents were mixed appropriately (Table 3-2). 
Table 3-2: Probe-to-water ratio at the box edges over the last 5 ns of simulation time, using 5 runs. The 
expected ratios differ slightly due to system setup. Upon introduction of the protein into a 50% w/w pre-
equilibrated solvent box, a random number of water and probes are removed from the system to avoid 
clashes with the protein. This can shift the probe:water ratio, thus slightly altering the composition of 
solvent in the system.  
 Elastase+ 
IPA 
Thermolysin 
+ IPA 
HEWL+ IPA RNaseA + 
IPA 
p53 core + 
IPA 
(Np/Nw)Obs 0.2114 0.2104 0.2276 0.2181 0.2489 
(Np/Nw)Exp 0.2212 0.2222 0.2219 0.2379 0.2208 
Obs/Exp 0.9557 0.9480 1.0255 0.9168 1.1271 
Np (simulation) 1949 2301 1459 1455 1847 
Nw (simulation) 8810 10355 6576 6116 8365 
 
HEWL was chosen as our initial validation protein because it is a simple canonical 
system with a wealth of available structural and binding data. IPA is a protic solvent with 
a slower diffusion rate than CCN and we were interested in comparing our results from 
HEWL+CCN to the HEWL+IPA system. The MSCS of HEWL contained only a single 
CCN bound at the active site, but two bound probes were identified in the MSCS of 
HEWL+IPA: IPA.2836 was bound in the active site and IPA.2837 was located on the 
opposite surface at the crystal interface.  
Although our previous MixMD study used the final 2 ns from a set of 10-ns 
simulations to identify hot spots, we have found that a wider window and longer 
simulation time was needed for obtaining converged data with a protic solvent. To 
calculate the optimal window size, we examined the data that resulted from combining 
the final 2-ns, 5-ns, 10-ns, 20-ns, 30-ns, and 40-ns segments of a 50-ns simulation. For 
example, the last 5 ns from five independent 50-ns trajectories of HEWL+IPA were read 
into ptraj and combined by the grid function to yield solvent occupancies for 25 ns of 
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total simulation time. For both HEWL and p53 core, we found that the final 5 ns of 
trajectory data best represented the probe sites from the converged simulation. Therefore, 
all of the data presented in this study has used a final-5-ns timeframe for the calculation 
of simulation occupancy grids.  
Length of the simulation was also examined. We analyzed the solvent occupancy 
from the first 10 ns (2-ns window), 20 ns (5-ns window for the following), 30 ns, 40 ns, 
and 50 ns. We found that by 50 ns the local minima had been sufficiently reduced such 
that only the relevant hot spots were located. Based on the proximity of the second IPA to 
the crystal packing interface and the small spherical density at that site (Table 3-1), we 
had hypothesized that IPA.2837 could be a water site, and our data supported this. We 
found that the maximal probe density converged to the location of the probe at the active 
site (Figure 3-3). Sizable water density was located the second IPA site and most of the 
low B-factor crystallographic waters from the MSCS (Figure 3-4). In cases where the 
refined density map indicates that the organic probe might actually be a water molecule, 
simulation density can aid in the proper assignment. Mapping water density and 
examining lifetimes of water at sub-sites have been established techniques for some time; 
our ability to map low B-factor waters demonstrates that MixMD does retain this 
functionality. This was shown in our previous paper on HEWL+CCN.182 Therefore, we 
focus our discussion of water occupancy to only the probe sites where the experimental 
density appears to support a water molecule. 
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Figure 3-3: MixMD data combined for the last 5 ns of 5 individual 50-ns runs of fully flexible HEWL in 
50% w/w IPA and water. All snapshots were superimposed on the starting crystal structure (PDB ID 1YL0, 
white surface). The MSCS coordinate positions for IPA.2836 and IPA.2837 are shown in cyan as ball-and-
stick. A) Simulation IPA density does map the IPA.2836 site using a 2-ns window after 10 ns of simulation, 
however many other spurious minima are mapped as well. B-F) Using a 5-ns window, we find that the 
local minima are eliminated over time as the simulation converges to the maximally occupied hot spot. 
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Figure 3-4: MixMD data combined for the last 5 ns of 5 individual 50-ns runs of fully flexible HEWL in 
50% w/w IPA and water. All snapshots were superimposed on the starting crystal structure (PDB ID 1YL0, 
white surface). Low B-factor (<33 Å) water sites are shown in black and the other water sites are shown in 
yellow. The MSCS coordinate positions for IPA.2836 and IPA.2837 are shown in cyan as ball-and-stick. 
Simulation water density overlays well with both A) the crystallographic water sites and B) the secondary 
IPA probe, IPA.2837. 
To determine the general applicability of 5 x 50-ns simulations as the optimal 
trajectory length for sampling with a protic solvent, we also applied MixMD to the 
MSCS of p53 core domain (PDB ID 2IOM). Although the crystal structure was missing 
residues 92-96 and 285-294, these residues are part of the disordered domain linkers and 
were not expected to impact mapping results. Experimentally, a single IPA molecule was 
bound to p53 core at the active site, and this was validated by the refined FO-FC density 
from Buster. As we found for HEWL+IPA, examination of 5-ns windows over the course 
of the trajectory showed that 50-ns of simulation time was sufficient for mapping hot 
spots with IPA while minimizing local minima along the p53 core surface (Figure 3-5). 
The crystallographic site matched our maximally occupied location from the simulation 
IPA density, demonstrating the capacity of MixMD to capture important binding sites in 
DNA-binding proteins.  
 68 
 
 
 
Figure 3-5: MixMD data combined for the last 5 ns for 5 individual 50 ns runs of fully flexible p53 core in 
50% w/w IPA and WAT. All snapshots were superimposed on the original crystal structure (PDB ID 2IOM, 
white surface). MixMD density is shown in blue for the IPA probe. The MSCS coordinate position for 
IPA.3001 is shown in cyan as ball-and-stick. The maximally occupied site for simulation IPA density 
clearly agrees with the crystallographic probe position. A) Simulation IPA density does map the IPA.3001 
site using a 2-ns window after 10 ns of simulation, however a few other spurious minima are mapped as 
well. B-E) Using a 5-ns window, we find that the local minima are eliminated over time as the simulation 
quickly converges to the maximally occupied hot spot. 
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Through MixMD simulations of HEWL+IPA and p53 core+IPA, we showed that we 
could map the protein hot spots correctly without simultaneous identification of 
numerous irrelevant minima. We could show other minima by decreasing the contour 
value, but that does not change the fact that the correct location is clearly identified by 
the highest-occupancy grid points. Our studies based on these two proteins indicated an 
optimal simulation time of 5 independent simulations of 50 ns and an analysis window of 
5 ns when running MixMD with a protic solvent.  
 
3.3.4. Determining the Appropriate Number of Simulations  
To study the consequence of the number of independent simulations, we compared 
the results from 5 runs of 50 ns each to 10 runs of 50 ns each for the larger protein 
systems, elastase and thermolysin. The success of MD simulations is firmly based on the 
assumption of the ergodic hypothesis: given adequate sampling, all relevant states will be 
reached. We prefer many shorter simulations run in parallel to increase sampling instead 
of one long simulation because they increase the potential space that may be explored. 
This is particularly true for computational studies of solvent mapping, where effective 
mapping must be balanced with an efficient use of computational cycles. Furthermore, 
long simulations should eventually unravel the protein. Many short simulations focus the 
maps on the more biologically relevant conformation of the protein. However, we need to 
determine if it is better for probe mapping.  
MSCS of elastase were solved in the presence of acetone, CCN, benzene with IPA, 
cyclohexane with IPA, dimethylformamide, ethanol, IPA, and trifluoroethanol. The large 
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amount of available crystallographic data enabled us to compare the results from MixMD 
of elastase+IPA/CCN in water to the experimental data for both IPA/CCN as well as 
other functional group probes. The MSCS structure of elastase+IPA contained three 
probe molecules; two were bound in the active site (IPA.1001 and IPA.1003), and the 
third was located near the crystal-packing interface (IPA.1002). Inspection of the 
symmetry partners revealed that IPA.1002 could also be located on an opposite face of 
elastase (referred to as IPA.1002x). Results from density refinement in CCP4i showed 
that all four locations were supported by the FO-FC density (Table 3-1).  
Our MixMD results for elastase+IPA were highly similar to the MSCS data for its 
corresponding crystal structure as well as the consensus MSCS data of many probe types 
in many crystal structures. Overlaying all of the MSCS structures and examining their 
electron densities of the probes indicated that IPA.1001 was the most populated 
consensus site, which confirmed our identification of IPA.1001 as the maximally 
occupied hot spot. The other IPA positions in the binding site were also identified within 
the top 8 hot spots. We found that solvent occupancies calculated from the middle of 10 
independent trajectories (15-20 ns) resulted in the better mapping when compared to the 
occupancies from the final 5 ns (45-50 ns) of 5 runs (Figure 3-6). Although 5 simulations 
performed over 50 ns were sufficient to show convergence, doubling the number of 
simulations decreased the amount of simulation required: 250 ns were required for 5 runs 
compared to 200 ns for 10 runs. After the first 20 ns for each of the 10 runs, the hot spot 
at IPA.1001 had been identified as the highest populated site and continued to be the 
primary hot spot for the duration of simulation time. Examination of the top eight hot 
spots showed that IPA.1001, IPA.1002, and IPA.1003 were each mapped, in addition to a 
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pocket close to IPA.1002x and several hot spots from other MSCS results, including sites 
with justified electron density for ethanol, dimethylformamide, and IPA. The other 
binding sites that were identified by probe or water density included crystallographic 
water positions and pockets near hydrogen-bonding residues Arg36 and Arg54. Although 
structure factor files were not available for elastase+CCN, our MixMD simulations of 
this system preferentially located the active site as well as several MSCS probe locations. 
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Figure 3-6: MixMD data combined for the last 5 ns of 5 individual 50-ns runs of fully flexible elastase in 
50% w/w IPA and WAT. All snapshots were superimposed on the original crystal structure (PDB ID 2FOF, 
white surface). The MSCS coordinate positions for IPA.1001, IPA.1002, and IPA.1003 are shown in cyan 
as ball-and-stick. The crystal interface probe site IPA.1002x is shown in gray. Alternate probes from other 
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MSCS by the same authors are shown in blue. Density contour levels were chosen such that the top eight 
hot spots were represented at a “hide dust” level of two. A) Results from performing FTMAP against 
PDBID 2FOF, with functional group clusters shown in pink. B) All probe sites from MSCS with elastase. 
C) Simulation IPA density from the last 5ns of 50 total ns from independent runs 1-5  (purple) and D) the 
last 5ns of 50 total ns from independent runs 6-10 (green) do not perform as well as the results from all 10 
runs. E) The maximally occupied site for simulation IPA density from the last 5 ns of 50 total ns from 10 
independent runs (blue) corresponds with all three the crystallographic probe positions as well as two 
other MSCS sites. F) Simulation IPA density from the last 5 ns of 20 ns total simulation time over 10 
individual runs performs better than the IPA density after 50 ns over 5 runs.  
 
Like elastase, thermolysin has also been used extensively for MSCS studies163,226 and 
well as other computational FBDD studies177,238,239, allowing us to compare our MixMD 
results to a wealth of experimental and computational data. The results from our 
simulations of thermolysin lent strong support to our emphasis on comparing simulation 
occupancy grids to the experimental density instead of to the crystallographic 
coordinates. Although several of the MSCS systems we have discussed had more than 
one solvent probe along the protein surface, the refined electron density has not always 
given a clear indication that the coordination position of the probe was justified. This was 
particularly true for thermolysin+IPA; although eight IPA molecules were specified in 
the PDB file, comprehensive analysis of the pre-generated density map from the Uppsala 
Electron Density Server235, the refined structure factor file, and the crystal contact region 
showed that none of the IPA molecules were placed in justified locations (Table 1). In 
fact, the FO-FC density map from the refined crystallography data did not indicate the 
existence of any probe sites at 2.5 σ . A number of the solvent-mapping procedures that 
have been published have used the probe positions in thermolysin to validate their 
technique, which further emphasizes the necessity of understanding the limitations of 
crystallographic data prior to performing validation analyses. 
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Although the refined FO-FC density did not support the placement of probes along the 
binding surface of thermolysin in this particular crystal structure, which was solved at 
90% IPA, this structure had been solved in concentrations ranging from 2 to 100% IPA 
by the same authors. Refinement of the electron density map for the 100% IPA crystal 
structure (PDB ID 8TLI) illustrates that some probe positions are justified based on 
structure factors in the MSCS at the highest probe concentration. The RMSD between 
7TLI and 8TLI is equal to 0.25 Å, allowing reasonable comparison between the MSCS 
density results for the two structures. Thus, the thermolysin was not the same as the 
RNase A case, and further exploration of simulation occupancy results was appropriate. 
Also, the strong emphasis on thermolysin as a test system for fragment binding made it 
an interesting case for developing our simulation protocol. On the basis of comparisons to 
the electron density data from 8TLI, we continued our investigation of the optimal 
trajectory length for MixMD of proteins with large binding surfaces. Refined FO-FC 
density revealed that the only potentially justified probe sites were IPA.2001, IPA.2006, 
and IPA.2008. The maximally occupied sites for IPA molecules correctly agreed with the 
position of the greatest probe density in the active site, the position of IPA.2001. We 
identified several other hot spots in the thermolysin active site, supported by the density 
for IPA.2008 and alternate TYR157 position A. As we saw for elastase, the use of 10 
runs of 50 ns each improved mapping results compared to 5 runs of 50 ns each (Figure 
3-7).  
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Figure 3-7: MixMD data combined for the last 5 ns of 5 individual 50-ns runs of fully flexible thermolysin 
in 50% w/w IPA and WAT. All snapshots were superimposed on the original crystal structure (PDB ID 
7TLI, white surface). The MSCS coordinate positions for IPA.2001, IPA.2006, and IPA.2008 are shown in 
cyan as ball-and-stick while the unjustified probe sites are shown in gray. The crystal interface probe sites 
are shown in green. Density contour levels were chosen such that the top eight hot spots were represented, 
and a “hide dust” level of three was used. A) Results from performing FTMAP against PDBID 7TLI, with 
functional group clusters shown in pink. B) Simulation IPA density from the last 5ns of 50 total ns from 
independent runs 1-5  (purple) and C) the last 5ns of 50 total ns from independent runs 6-10 (green) do not 
perform as well as the results from all 10 runs. D) The maximally occupied site for simulation IPA density 
from the last 5 ns of 50 total ns from 10 independent runs (blue) corresponds with all three the 
crystallographic probe positions as well as two other MSCS sites. E) Simulation IPA density from the last 5 
ns of 20 ns total simulation time over 10 individual runs performs better than the IPA density after 50 ns 
over 5 runs.  
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Our results for the appropriate number of simulation runs to perform for MixMD 
were particularly relevant to a common assumption in studies of hot-spot mapping, which 
holds that individual simulation densities should converge to the correct hot spot. We 
found this assumption to be invalid. Individual simulations all showed some occupancies 
at the principal sites of probe interaction, but they diverged in their identification of the 
global minimum. They also diverged in their positions for spurious sites. Combining the 
simulation data best represented the true binding potential of the protein and eliminated 
irrelevant minima. We found that for both elastase and thermolysin, solvent occupancy 
grids from the 10 runs outperformed simulation occupancy from only 5 runs, where 
performance was defined as the number of crystallographic probe sites found within the 
top-ranked hot spots. We focused our examination of hot spots on the top eight probe 
sites that were well-occupied by simulation density and required that they correspond 
with most of the crystallographic hot spots to demonstrate success.  
  
3.3.5. Allowing for Conformational Change 
There are occasions when a MixMD map may not reproduce the MSCS probe 
coordinates. In cases where conformational rearrangement of the protein alters the 
solvent accessible surface area in the binding site, the available interactions may change 
relative to the original crystal structure. The crystal structure of RNase A was solved such 
that a salt bridge was formed between Asp121 and a neighboring residue in a symmetry 
partner. When MD simulations were performed in the absence of the crystalline 
environment, this salt bridge no longer existed and Asp121 shifted towards the active 
site. This caused the binding cavity to narrow, with a new distance of 10.2 Å from Val43-
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Asp121 compared to an original distance of 11.6 Å. However, the interactions available 
at these sites was altered over the course of simulation due to a median RMSD shift of 
4.54 Å from the crystal structure, according to the final 5 ns from 5 independent 
simulations of 50-ns each for RNase A+IPA.  
RNase A binds and cleaves RNA substrate in a deep cleft flanked by the two catalytic 
residues, His12 and His119, through a transition state complex that is stabilized by the 
presence of three basic residues: Lys9, Lys41, and Lys66. The MSCS of RNAse A (chain 
B) had coordinates for two IPA probe molecules at the active site, each with B-factors 
over 60 Å. IPA.902 was principally associated with His12 and Thr45, while IPA.903 
interacted with His12 through a bridging water (Wat921). The refined map of 3EV2 from 
Buster, obtained using the original PDB structure with the IPA molecules removed 
individually, showed that the density for IPA.902 was more compelling as a probe site 
than the density for IPA.903. We found that the FO-FC density of the active site indicated 
a justified probe site at IPA.902B and the expected density for a water molecule at 
IPA.903B. 
The maximally occupied site for probe occupancy from simulation IPA density was 
located in a deep pocket next to Asp121 (Figure 3-7), where the probe was able to form a 
stable hydrogen-bonding interaction due to the conformation shift that occurred in 4 of 
the 5 simulations. The second site identified by probe density overlapped with the 
position of a cytosolic RNase inhibitor bound across the active site (PDB ID 3MWQ240). 
Without experimental confirmation of the structural changes observed in our simulation, 
it is not possible to judge the validity of these findings. 
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Figure 3-8: MixMD data combined for the last 5 ns of 5 individual 50 ns runs of fully flexible RNase A in 
50% w/w IPA (blue) and water (water). All snapshots were superimposed on the crystal structure (PDB ID 
3EV2, white surface). Crystallographic waters are colored black for B-factors < 33 Å and in yellow for B-
factors > 33 Å. Water molecules that were identified along the crystallographic boundary are not shown. 
The MSCS coordinate positions for IPA.905A, IPA.917A, IPA.902B, and IPA.903B are shown in cyan as 
ball-and-stick. MSCS with other functional groups obtained by the same authors are shown in blue, FTMap 
sites are shown in pink. A) The MSCS probe sites from 3EV2 chain B. B) The consensus MSCS probe sites 
with a variety of different solvent probes. C) The cluster sites from performing FTMAP against chain B of 
3EV2. D) The simulation density for the probe occupancy over the final 5 ns of the combined runs.  E) The 
simulation density for the water occupancy of the final 5 ns of the combined runs. 
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We found that our occupancy grid for water mapped the binding site, including the 
position of IPA.902 and a secondary binding site between IPA.902B and IPA.903B, 
which was well-positioned to take advantage of contacts to His12 and Lys41. Over the 
course of our MD simulation, the conformational shift caused by movement of Asp121 
caused the β-sheet that contained His119 to move downward, which oriented His119 into 
the position occupied by Wat921 in the crystal structure. This affected mapping of the 
binding site, and the secondary site is likely the equivalent of the density assigned to 
IPA.903B in the crystal structure. Our combined solvent occupancy (IPA+water) mapped 
the bound position of IPA.917A of 3EV2, which lies along the protein surface in a 
shallow binding pocket near Thr60. Only sixteen of the crystallographic water positions 
were within 5 Å of the protein and had B-factors of < 33 Å; all but one of these positions 
was strongly mapped by our water occupancy grids. 
These results for RNase A + IPA indicated that a lower concentration of probe may 
be required for mapping in order to correctly identify the active site. It is unclear based 
on the available data whether or not the conformation observed in our simulation is valid 
for this protein system, or whether the solvent concentration has influenced the 
conformational ensemble towards an unfolded state. As a result, it would be interesting to 
determine the impact of a lower concentration of solvent on conformational sampling and 
probe mapping in our simulations. 
 
3.4 Conclusions 
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Our results demonstrated the utility of MixMD for identifying the hot spots present in 
a broad range of pharmaceutically-relevant receptor targets. We have shown that both 
protic and aprotic solvent types can be used in MixMD to specifically model the 
consensus sites for binding as a complementary technique to experimental FBDD. 
Evaluation of the FO-FC omit density generated based on the refined structure with 
probe(s) removed showed the importance of thoroughly examining the experimental data 
in a test set to ensure fair and accurate comparison. In all cases, true hot spots in the 
crystal structure were located by the simulation density. The additional hot spots that 
were identified by solvent occupancies from MixMD were judged to be reasonable based 
on other crystal structures, the surrounding binding surface, and analysis of the crystalline 
interface. Our study has determined the optimal simulation length and run number for 
mapping probe sites within overabundant local minima. Probe concentration should be 
explored in order to determine its influence on true conformational change or partial 
unfolding. 
We have stressed the importance of performing careful validation studies when 
developing an approach to solvent mapping like MixMD. We have examined both the 
optimal simulation length and number needed for broadly applying MixMD studies to 
diverse protein cases. Our study found that an analysis of computational solvent mapping 
that is based on simulation density can result in identification of binding sites that are not 
overshadowed by overabundant local minima. 
 
This work is in preparation for submission: Lexa KW and Carlson HA. 2011.  
 
